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Abstract
Title: Ultrasound measurements on the inferior vena cava (IVC-US) by renal nursing staff for
assessment and management of intravascular volume status in haemodialysis patients.
Aims: The primary aim of this thesis was to provide evidence that renal nurses could safely and
efficiently perform IVC-US on haemodialysis patients to obtain objective assessment of intravascular
volume status and potentially reduce adverse events and morbidity.
The secondary aims for this study were: (1) conduct a systematic literature review to identify evidence
if renal nurses have previously used this method for intravascular volume assessment; (2) teach a
renal nurse through a staged educational programme, guided by a medically trained ultrasonographer, a sonologist, to gain competency in ultrasound image acquisition and interpretation of
the scans; (3) measure the prevalence of any form of intradialytic hypotension in a satellite
haemodialysis clinic over a three-month period and (4) attain concurrent IVC-US and bioimpedance
spectroscopy measurements on 30 patients during their haemodialysis treatment and to compare
these findings with their intravascular volume status using the traditional clinical nursing assessment
method.
Materials and Methods: To achieve this primary aim, this thesis was separated into multiple phases.
First, a systematic literature review of medical and nursing databases was performed to summarise
the use of IVC-US in haemodialysis patients by renal nurses. The second phase involved a
retrospective data analysis, where the prevalence rate of nurse-documented fluid related intradialytic
hypotensive events was measured and a Generalised Estimating Equation (GEE) model was used to
predict the likelihood of any form of intradialytic hypotension or postdialytic overhydration. In the next
phase a four-step educational programme was developed in collaboration with an expert sonologist,
guiding the renal nurse through the process of skill acquisition and accurate fluid assessment based
on nurse-performed IVC-US scans. Following this phase, and after receiving theoretical training and
performing 100 proctored scans, the renal nurse then performed 60 IVC-US scans independently,
which were subsequently assessed by two sonologists, resulting in a cross-sectional interrater study,
confirming competency. The final phase of the thesis consisted of a simulative pilot study, where 30
haemodialysis patients were assessed during three intradialytic moments of a single session on their
intravascular volume status with IVC-US.
Results: The systematic literature review revealed that there is a paucity of knowledge regarding
renal nurses and IVC-US. The 3-month data analysis has shown that intradialytic hypotension (IDH)
was still the most common adverse intradialytic event with 13.1% of all treatments affected. The renal
nurse mastered the educational programme and was deemed competent by the experts. Finally, the
simulative pilot study revealed that if IVC-US had been performed and indicated intravascular
hypovolemia, patients had a 14-fold chance to experience subsequent IDH events. An algorithm using
IVC-US combined with bioimpedance spectroscopy (BIS) and mean arterial pressure (MAP) revealed
a sensitivity of 95% and a specificity of 100% for the prevention of IDH.
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Conclusions: This thesis demonstrates the obvious need for more objective and reliable fluid
assessment methods in the haemodialysis population to improve clinical outcomes. Most importantly,
it has been shown that renal nurses can master the skill to perform IVC-US and that IVC-US is a
useful and reliable method of fluid assessment. Performing IVC-US is a transferrable skill and has
potential to be preventative for intradialytic hypotension if added to the clinical fluid assessment
routine by renal nurses. It has potential to change clinical practice and policy in future, but further
research studies are needed to provide evidence for this.

Keywords: haemodialysis, renal nurses, intradialytic hypotension, ultrasound inferior vena cava, nursing
competency, interrater reliability, intravascular volume status, point of care ultrasound, symptomatic hypotension,
asymptomatic hypotension, overhydration, fluid overload, satellite dialysis, clinical skills, fluid assessment,
hydration status, nurse education, nursing skills, prevention

iii

Table of Contents
Abstract ................................................................................................................................ ii
List of Tables........................................................................................................................ vi
List of thesis publications by candidate .............................................................................. vii
Statement of Originality of Authorship ..............................................................................viii
Statement of Contribution of Others .................................................................................. ix
Copyright Declaration ........................................................................................................xiv
Acknowledgements .............................................................................................................xv
List of abbreviations used ..................................................................................................xvi
Introduction ......................................................................................................................... 1
Haemodialysis and intradialytic hypotension (IDH) ....................................................................... 1
Aims of this thesis ......................................................................................................................... 4
Research questions........................................................................................................................ 4
Research objectives ....................................................................................................................... 5
Significance ................................................................................................................................... 6
Scope ............................................................................................................................................. 6
Structure of this thesis .................................................................................................................. 6

Chapter 1 .............................................................................................................................. 9
Intradialytic hypotension – Definition, prevalence rates and preventative methods .................... 9
1.1 General Introduction ........................................................................................................ 9
1.2 Predialytic fluid assessment ............................................................................................. 9
1.3 Definition of IDH and clinical symptoms ......................................................................... 11
1.4 Reported prevalence rates of IDH................................................................................... 12
1.5 Potential causes and treatment of IDH events ................................................................ 12
1.6 Clinical outcomes of IDH events ..................................................................................... 14
1.7 Intradialytic fluid assessment methods........................................................................... 14

Chapter 2 ............................................................................................................................ 20
2.

Literature Review .............................................................................................................. 20
2.1 Foreword ....................................................................................................................... 20
Use of ultrasound by registered nurses – a systematic literature review .................................... 21
2.2 Additions to the systematic literature review (from 2015 to 2017) ................................. 32
2.3 Conclusion ..................................................................................................................... 35

Chapter 3 ............................................................................................................................ 37
The prevalence rate of Intradialytic hypotension ........................................................................ 37
3.1 Introduction ................................................................................................................... 37

Chapter 4 ............................................................................................................................ 49
4.

The educational programme for renal nurses to perform IVC-US ..................................... 49
4.1 Introduction ................................................................................................................... 49

iv

Chapter 5 ............................................................................................................................ 58
Assessing nursing competency in volume assessment using IVC-US............................................ 58
5.1 Introduction ................................................................................................................... 58

Chapter 6 ............................................................................................................................ 69
6.
Correlation and predictive value of IVC-US with BIS when observing for intravascular
volume ........................................................................................................................................ 69
6.1 Introduction ................................................................................................................... 69

Chapter 7 ............................................................................................................................ 88
7.

Discussion ......................................................................................................................... 88
7.1 Introduction ................................................................................................................... 88
7.2 Overview of major findings............................................................................................. 88
7.2.1
IVC-US as a tool for renal nurses ................................................................................. 88
7.2.2
The prevalence rate of intradialytic hypotension (IDH)................................................ 89
7.2.3
The educational programme for renal nurses to perform IVC-US and to attain
competency .............................................................................................................................. 92
7.2.4
Assessing nursing competency in volume assessment using IVC-US ............................ 93
7.2.5
Predictive value of IVC-US and BIS when observing for intravascular volume .............. 94
7.2.6
Summary of major findings ......................................................................................... 97
7.3 Limitations ..................................................................................................................... 99
7.4 Recommendations for policy, practice and research ..................................................... 100

Chapter 8 .......................................................................................................................... 104
8.

Conclusion....................................................................................................................... 104

References........................................................................................................................ 107
Appendices ....................................................................................................................... 114
Copyright declaration for systematic literature review article (Journal of Renal Care) 2017 ..... 114
Copyright declaration for interrater study article (Hemodialysis International) 2017 ............... 115
Copyright declaration for Prevalence article (Journal of Clinical Nursing) 2018 ........................ 117
Renal Society of Australasia Communiqué 2017 ....................................................................... 118
The Raine Medical Research Foundation Annual Report 2015 .................................................. 119
The Raine Medical Research Foundation Annual Report 2016 .................................................. 120
The Raine Medical Research Foundation Annual Report 2017 .................................................. 122
Certificate of attendance – Renal Society of Australasia – WA Branch Meeting Perth 2017...... 124
Renal Society of Australasia WA Branch Symposium Program 2017 ......................................... 125
Certificate of attendance - Renal Society of Australasia – Annual Conference Sydney 2017 ..... 126
Renal Society of Australasia – Annual conference Sydney 2017 – Abstract submission ............ 127
Renal Society of Australasia - Annual conference program Sydney 2017 .................................. 128
Fremantle Hospital Medical Research Foundation Annual report 2013/2014 ........................... 129
STROBE checklist for cross-sectional studies ............................................................................. 130
STROBE checklist for observational studies ............................................................................... 132

v

List of Tables
Table 1-1 IVCCI cut-offs according to the ‘Guidelines for the Echocardiographic Assessment of the Right Heart
in Adults’ ……………………………………………………………………………………………………………………………………………….……… 18
Table 1-2 Indexed vena cava diameter corrected for body surface area (VCDi) cutoffs according to 'Echography
of the Inferior Vena Cava is a Simple and Reliable Tool for Estimation of 'Dry weight' in Haemodialysis
Patients'(Cheriex, Leunissen, Janssen, 1989) …………………………………………………………………………………….…………… 18

vi

List of thesis publications by candidate
Published Journal Papers:
1.

Steinwandel, U., Gibson, N.P., Rippey, J.C.R., Towell, A. & Rosman, J. (2017) Use of ultrasound by
registered nurses-a systematic literature review. Journal of Renal Care 43 (3),132-142
DOI:10.1111/jorc.12191

2.

Steinwandel, U., Gibson, N.P., Towell, M., Rippey, J.C.R. & Rosman, J. (2017) Can a renal nurse
assess fluid status using ultrasound on the inferior vena cava? A cross-sectional interrater study.
Hemodialysis International 21 (4), DOI:10.1111/hdi.12606

3.

Steinwandel, U. (2017) Intradialytic hypotension – A daily challenge for each one of us – Could
ultrasound of the inferior vena cava provide us with a better understanding of the intravascular volume
status Renal Society of Australasia Communiqué 20 (1),11-12

4.

Steinwandel, U., Gibson, N.P., Towell, M., Parsons, R., Rippey, J.C.R & Rosman, J. (2018) Measuring
the prevalence of intradialytic hypotension in a satellite dialysis clinic: Are we too complacent? Journal
of Clinical Nursing, https://doi.org/10.1111/jocn.14309

5.

Steinwandel, U., Gibson, N.P., Towell, M., Rippey, J.C.R & Rosman, J. (2018) Educating renal nurses
– inferior vena caval ultrasound for intravascular volume assessment Renal Society of Australasia
Journal 14 (2), 59-64

Journal manuscripts under review:
1.

Steinwandel, U., Gibson, N.P., Towell, M., Parsons, R., Rippey, J.C.R & Rosman, J. (2018) Does the
intravascular volume status in haemodialysis patients measured by inferior vena cava ultrasound
correlate with bioimpedance spectroscopy?

Conference presentations
1.

Renal Society of Australasia (RSA) Annual Conference 19-21st June, Convention Centre, Sydney,
presentation: ‘Ultrasound of the inferior vena cava for volume assessment – Can renal nurses master
this skill?’, Steinwandel, U.

2.

Renal Society of Australasia (RSA) WA Branch Symposium ‘Changing Climate’, 12th August 2017,
Parmelia Hilton, Perth, presentation: ’Ultrasound by nurses – meeting the challenge of fluid assessment’
Steinwandel, U.

Annual Reports
1.

Fremantle Hospital Medical Research Foundation, Annual Review 2013/2014, page 17, ‘Using
ultrasound to better manage kidney dialysis’, Steinwandel, U.

2.

Raine Medical Research Foundation, Raine Annual Report 2015, page 63, ‘Do ultrasound
measurements of the inferior vena cava (IVC-US) by nursing staff improve assessment of the
intravascular volume status in the satellite haemodialysis clinic settings?’, Steinwandel, U.

vii

Statement of Originality of Authorship
I certify that this thesis does not, to the best of my knowledge and belief:
(i) incorporate without acknowledgement any material previously submitted for a degree or diploma in
any institution of higher education;
(ii) contain any material previously published or written by another person except where due reference
is made in the text; or
(iii) contain any defamatory material.
(iv) I also grant permission for the Library at Edith Cowan University to make duplicate copies of my
thesis as required.

Signed:

Date:

4th September 2018

(Ulrich Clemens Steinwandel)

viii

Pages ix – xiv, Statement of Originality of Authorship, are not included in this version of the thesis

Acknowledgements

Completion of this Doctoral research would not have been possible without the support and
assistance of various individuals throughout the research project. I would like to express my sincerest
gratitude to my Principal Supervisor, Dr. Nick Gibson and Associate Supervisor Dr. Amanda TowellBarnard. I would also like to express my appreciation to my clinical mentors Prof. James Rippey and
Prof. Johan Rosman. Their support, guidance and professional advice provided throughout the
duration of this project has been vital and I feel privileged that I received their professional assistance.
I also would like to thank Prof. Paolo Ferrari, the previous Head of Department of Fremantle Hospital
who initially helped me in formulating my research question.
I am further very grateful for the generous support of the Raine Medical Research Foundation, in
particular from Mrs Lyn Ellis, who always showed positive support for this project. I would also like to
thank Mr. Russell McKenney from the Spinnaker Health Research Foundation for the ongoing
encouragement.
Additionally, I want to thank Samantha Tan from Fresenius Medical Care, who gave me permission to
perform this research project in two Fresenius satellite dialysis clinics in the Perth Metropolitan area.
Finally, I would like to thank my beloved wife Anke Steinwandel for her staggering patience and
diligence with the ongoing upbringing of two special sons and many challenging situations over
sometimes endless 4 years, while her husband was frequently invisible.

xv

List of abbreviations used
Abbreviation

Meaning

A-IDH

Asymptomatic intradialytic hypotension

BIS

Bioimpedance spectroscopy

BCM

Body Composition Monitor

BMI

Body Mass Index

BP

Blood pressure

BSA

Body surface area

BVM

Blood Volume Monitor

EFV

Extracellular fluid volume

ESRD

End-stage renal disease

FMC

Fresenius Medical Care

GEE

Generalised Estimating Equation

HD

Haemodialysis

HDF

Haemodiafiltration

IDH

Intradialytic hypotension

IDWG

Interdialytic weight gain

IV

Intravenous

IVC

Inferior vena cava

IVCd

Inferior vena cava diameter

IVCdimin

Indexed minimum inferior vena cava diameter

IVCdimax

Indexed maximum inferior vena cava diameter

IVCmin

Minimum inferior vena cava diameter

IVCmax

Maximum inferior vena cava diameter

IVCCI

Inferior vena cava collapsibility index

IVC-US

Ultrasound of the inferior vena cava

IBW

Ideal Body Weight

KDOQI

Kidney Disease Outcome Quality Initiative

LA

Long axis

LUS

Lung ultrasound

LVH

Left ventricular hypertrophy

xvi

MAP

Mean arterial pressure

MFBIA

Mulitfrequency bioelectrical impedance analysis

NKF

National Kidney Foundation

NQF

National Quality Forum

OH

Overhydration

POCUS

Point-of-care ultrasonography

QIP

Quality Incentive Program

RBV

Relative blood volume

RCT

Randomised controlled trial

RRT

Renal Replacement Therapy

SA

Short axis

SBP

Systolic blood pressure

S-IDH

Symptomatic intradialytic hypotension

TDMS

Therapy Data Management System

UF

Ultrafiltration

UFR

Ultrafiltration rate

UK

United Kingdom

US

Ultrasound

VCDi

Indexed vena cava diameter

WA

Western Australia

.

xvii

Introduction
Haemodialysis and intradialytic hypotension (IDH)
This first chapter describes some of the daily challenges renal nurses in Western Australia (WA) face when they
perform the technical procedure of haemodialysis (HD) on patients under their care. Satellite HD clinics in WA
are nurse-led, which means there are generally no doctors present when treatments are performed. This
implies that renal nurses have the sole responsibility for the assessment of the patient for safe performance of
treatments and they have to prevent patients from unnecessary harm or adverse events. The nursing care
they deliver is determined by their standards of practice according to the definitions outlined by the Nursing
and Midwifery Board of Australia (Cashin et al., 2017).
In 2012 there were 11,446 chronic dialysis patients in Australia (Briggs, Hurst, McDonald, & Clayton, 2013). The
majority (61%) of these receive HD treatment three times per week for up to five hours per session in a
satellite dialysis clinic as outpatients across all states and territories of Australia (Briggs et al., 2013). HD is a
medical treatment which aims to remove excess fluid and metabolic waste products in patients with end stage
renal disease (ESRD), which is equivalent to stage five chronic kidney disease (CKD) (Mahon, Jenkins, &
Burnapp, 2013). CKD is a clinical condition, characterised by a gradual loss of kidney function over time
predominantly caused by hypertension and diabetes mellitus (Thomas, 2013). Patients with CKD usually start
with ongoing HD treatment once their kidney function declines below a glomerular filtration rate (GFR) of < 79 mL/min/1.73 m2 in combination with worsening of clinical symptoms (Thomas, 2013). Symptoms include
fluid retention, fatigue and weakness caused by an increase in metabolic substances which are normally
excreted in the urine (Mahon et al., 2013). Furthermore, HD aims for a physiological balance of electrolytes
and blood pH in addition to normalisation of the blood pressure (Thomas, 2013).
Prior to a regular HD session and for assessment of the clinical condition of a patient, a renal nurse performs a
brief visual observation for any signs of fluid overload such as oedema (swollen ankles or legs), shortness of
breath or elevated jugular vein pressure (Mahon et al., 2013, p. 384), and the patient is weighed. It is assumed
that this gain of bodyweight since the last treatment represents the accumulated fluid that would have been
normally excreted by the kidneys. Then, the renal nurse calculates and decides on an individual fluid removal
(ultrafiltration (UF) goal in ml) for the present treatment. This decision is mainly based on the bodyweight gain

1

of the patient since the last treatment, the current blood pressure and the clinical condition. This UF goal will
then be entered into the HD machine and the patient will be connected via two cannulae and an
extracorporeal blood circuit onto the machine. The HD machine then gradually removes the pre-set volume of
fluid from the patient’s blood by negative (hydrostatic) pressure in the dialyser, an artificial blood filter which
removes fluid and metabolic substances. Over 4 to 5 hours it is expected that the patient achieves the
calculated fluid volume removal upon cessation of the session without clinical complications and is able to
leave the satellite dialysis clinic in a stable physical condition (Mahon et al., 2013). Renal nurses, as part of the
assessment also need to establish a new, or review an established ideal body weight (IBW) regularly for each
patient as the major guideline for the UF goal for each dialysis session (Kinton, 2005). IBW is defined as the
“lowest tolerated post dialysis weight at which there are minimal signs or symptoms of hypovolemia or
hypervolemia” (Sinha & Agarwal, 2009).
In all WA satellite dialysis units, there are no doctors available on-site during treatment hours, which means
nurses are responsible for making critical decisions regarding the amount of fluid to be removed, a crucial
determinant of a patient’s well-being and morbidity. Fluid removal during HD is essential for maintaining the
overall condition of patients with ESRD. Sometimes HD patients experience adverse events during dialysis,
often due to intradialytic hypotension (IDH) (Burton, 2009, p. 48).
The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI) is an American
institution which provides yearly updates on evidence-based clinical practice guidelines for all stages of CKD
and related complications. These guidelines are internationally recognised to improve the quality of life of
many patients with CKD. The NKF KDOQI guidelines define IDH as: “A decrease in systolic blood pressure ≥ 20
mmHg or a decrease in mean arterial pressure by 10 mmHg associated with symptoms that include: abdominal
discomfort, yawning, sighing, nausea, vomiting, muscle cramps, restlessness, dizziness or fainting and anxiety.
These clinical events indicate the need for nursing interventions.”(National Kidney Foundation Inc., 2005)
This symptomatic IDH (S-IDH) is normally caused by an UF goal which has been chosen too high or has been
achieved too fast and it can be managed by adjusting the UF goal on the dialysis machine and administering IV
saline (Hayes & Hothi, 2011). IDH can also occur without any clinical symptoms as asymptomatic IDH (A-IDH)
and has been defined as a systolic blood pressure (SBP) lower than 100mmHg without symptoms (Chesterton,
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Selby, Burton, & McIntyre, 2009). The Hemodialysis (HEMO) study with 1426 participants revealed that IDH
occurred in a median of 12.5% of dialysis sessions and required nursing interventions including administration
of intravenous administered saline and a reduced ultrafiltration rate (Sherman & Kapoian, 2011). These
authors support reducing the frequency of IDH as it can cause cardiac stunning, leading ultimately to
irreversible heart damage. Moreover, it increases the risk for vascular access thrombosis (VAT), which is critical
for HD patients as their arteriovenous fistula (AVF) is their primary option for connecting to the HD machine
(Mahon et al., 2013; Sherman & Kapoian, 2011). The AVF is a surgically created vascular access, an artificial
shortcut between an artery and a vein and is the vascular access of choice for HD. An AVF is necessary to
perform maintenance HD, as during each session large blood volumes, typically around 90 litres per session,
need to be circulated through the HD machine to achieve adequate dialysis (Ganie, Lone, Dar, Lone, & Wani,
2013). Although the native AVF is regarded as the vascular access of first choice and is predominantly used in
Australia, central venous catheters (CVC) are also often placed in patients requiring dialysis and they appear
not to be adversely affected from VAT (following an episode of IDH) due to their technical characteristics when
compared to AVF (Roberts, Polkinghorne, McDonald, & Ierino, 2011).
One potential impact of conventional HD is recurrent systemic circulatory stress on multiple organ systems
such as the heart, brain, gut and the kidneys (McIntyre, 2010). This is important as not all patients with ESRD
on HD have completely lost their kidney function, and some patients are left with a reasonable fluid excretion
function (Davenport, 2016). Adverse events during treatment such as IDH have a negative impact on residual
kidney function and could have irreversible consequences on the long-term quality of life of patients
(McIntyre, 2010). Yet, renal nurses who witness the occurrence of IDH daily have only a few objective
parameters available to determine a patient’s fluid status, such as blood pressure and body weight. They must
assume that the patient’s blood pressure status throughout the course of HD reflects the current intravascular
fluid status, due to the lack of any other non-invasive objective parameters.
Brennan et al. (2006) demonstrated that the ultrasound (US) assessment of the inferior vena cava (IVC) can be
useful for evaluating the volume-status of a patient. Their study also revealed that medical residents with
minimal echocardiographic training could adequately measure the IVC with a portable ultrasound device.
When compared to previous studies their achievement of obtaining high-quality pictures was only slightly
lower (89%) than those of experienced sonographers (94%). Importantly, they also demonstrated that almost
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50% of their patients were volume depleted at the start of their dialysis session. They concluded that an IVCUS was an achievable option for swiftly assessing the intravascular fluid status in a renal outpatient clinic
setting.
Renal nurses are crucial to monitoring and improving fluid assessment of their patients as they see their
patients for extended periods at least three times per week, which is much more often than renal consultants
(Chamney, 2007; San Miguel, 2010). Evidence shows medical residents achieved good ultrasound skills with
minimal training, so it is postulated that renal nurses would also be able to learn this skill and use it to
potentially enhance fluid assessment in HD patients. As such, this project sets out to assess whether trained
renal nurses can safely and efficiently perform IVC-US measurements on HD patients to objectively assess their
fluid status, ideally better defining the intended UF goal for the dialysis session and thus reducing the risk of
IDH.

Aims of this thesis
To provide evidence that renal nurses could safely and efficiently perform ultrasound on the inferior vena cava
(IVC-US) on HD patients to obtain an objective assessment of intravascular volume status and potentially
reduce adverse events and morbidity.

Research questions
Considering the issues described above in determining the objective measurement of the intravascular volume
status of HD patients during their treatment, the following research questions have been articulated for this
thesis:
Primary question
Can a renal nurse safely and efficiently perform IVC-US on HD patients and obtain an objective assessment of
their fluid status, and could these findings potentially lead to improved health outcomes for patients?
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Secondary questions
•

What is the prevalence rate of intradialytic hypotension episodes in a nurse-led satellite HD clinic in
Western Australia (WA)?

•

Is the traditional predialytic clinical fluid assessment performed by renal nurses efficient and/or
sufficient to prevent adverse events of intradialytic hypotension?

•

Is there any evidence that highlights renal nurses have previously performed IVC-US to determine
intravascular volume status in HD patients?

•

What is the design and structure of an educational programme for renal nurses to successfully
acquire the skills for IVC-US?

•

Can a renal nurse learn the skill of IVC-US as taught by a sonologist and gain competency to perform
IVC-US and objectively assess the intravascular volume status of a HD patient?

•

Does the intravascular volume status in HD patients measured by IVC-US correlate with other
validated techniques such as bioimpedance spectroscopy (BIS)?

•

Could renal nurse-initiated IVC-US reduce the incidence of IDH and lead to better patient outcomes?

Research objectives
At the end of this thesis the candidate will have achieved the following research objectives:
1.

performed a structured systematic literature review to find relevant peer-reviewed articles in regard
to the use of IVC-US by renal nurses for intravascular volume assessment

2.

measured the prevalence of S-IDH, A-IDH and post-dialysis overhydration in a satellite HD clinic over a
three-month period

3.

developed and instructed a renal nurse through a staged educational programme guided by a
sonologist to gain competency in ultrasound image acquisition and interpretation of the scans

4.

obtained simultaneously BIS and IVC-US scans on 30 patients over the course of a single treatment
session and compare the findings on intravascular volume status with the traditional clinical
assessment method

5.

hypothesised on the usefulness of IVC-US in preventing adverse events during HD
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Significance
The significance of this thesis is that it is the first to explore the use of IVC-US in renal nurse clinical practice.
IVC-US has been shown to reliably visualise intravascular volume status at any intradialytic time, providing the
observer with essential information to reconsider initial decisions. This could potentially be preventative for SIDH and A-IDH episodes, which represent the most common adverse events during HD. This thesis also
provides detailed insight into the prevalence rate of both forms of IDH in a typical Western Australian satellite
dialysis clinic. During this research, an educational programme evolved, consisting of four consecutive stages,
which demonstrated the feasibility and success of such a programme in the transferability of skills. Results
from this research gives the renal clinical community potential evidence to explore novel avenues when
intending to perform more accurate fluid assessments on patients. This thesis has provided essential
information to inform clinical practice, which can be considered when policymakers critically review existing
policies and procedures.

Scope
The scope of this thesis was limited to adult HD patients on maintenance HD in two satellite HD clinics in the
wider Perth Metropolitan area. The patient cohorts in both clinics were deemed indicative of the general HD
population in Western Australia (WA). Satellite HD clinics provided detailed nursing progress notes recorded in
an electronic database, allowing for extensive data analysis, and the Body Composition Monitor (BCM), a fluid
assessment tool used in conjunction with IVC-US for the intervention, and explained in more detail later in this
thesis.

Structure of this thesis
This thesis consists of eight chapters. The introductory chapter describes the adverse event of intradialytic
hypotension and its diversity in clinical symptoms. It also includes possible causes of intradialytic hypotension,
known prevalence rates and links to morbidity and mortality. It further comprises an overview of current fluid
assessment tools, aims of this thesis, research questions, and the significance of this study.
Chapter 1 provides an introduction to the topic ‘Intradialytic hypotension’, giving an overview on the
definition, prevalence rates and existing preventative methods
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Chapter 2 presents the findings from the systematic literature review regarding the use of IVC-US by nurses in
general and in the context of fluid assessment in HD patients. It focuses on research objective 1.
Chapter 3 describes results of a study on the prevalence rate of IDH in a West Australian satellite HD clinic and
links to research objective 2.
Chapter 4 describes an educational ultrasound programme, comprising four stages through which competency
in performing IVC-US for a renal nurse can be achieved. This chapter relates to research objective 3.
Chapter 5 describes the results of a study on the comparison of a renal nurse’s fluid assessments obtained
from IVC-US compared to two sonologists, and also focuses on research objective 3.
Chapter 6 presents the findings from a study on the comparison of 2 additional fluid assessment methods with
the traditional clinical fluid assessment method, relating to research objective 4.
Chapter 7 summarises and discusses all findings gained from the studies included in this thesis. Additionally,
suggestions are made for future research studies. This chapter relates particularly to research objective 5.
Chapter 8 provides the conclusions of this thesis.

7
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Chapter 1
Intradialytic hypotension – Definition, prevalence rates and preventative methods

1.1

General Introduction

This chapter begins with a description of how a predialytic fluid assessment is typically performed by renal
nurses, allowing a renal nurse to determine an UF goal specific for the patient. This is followed by the
definition of IDH, including the range of clinical symptoms of IDH, currently known prevalence rates and
patient characteristics. Potential causes and the clinical interventions when IDH occur are described, as well as
clinical outcomes such as morbidity and mortality. Finally, commonly used intradialytic fluid assessment
methods are summarised to specify the range of different approaches and techniques.

1.2

Predialytic fluid assessment

Patients with end-stage renal disease (ESRD) require ongoing renal replacement therapy (RRT) for the
remainder of their life or until kidney transplantation occurs. The vast majority of these patients in Western
Australia receive maintenance HD three times per week, typically with a minimum of four hours each session
(Briggs et al., 2013). Most of these routine sessions occur in outpatient satellite HD clinics, close to the
patient’s home and are run by specialised renal nurses but without direct medical supervision (Davenport,
2006). One of the major goals of HD is the removal of excess fluid from extracellular space, as well as removing
metabolic waste products and other goals such as balancing of electrolytes and pH levels (Chamney, 2007; San
Miguel, 2010).
Removal of excess fluid during HD is achieved through ultrafiltration (UF) during HD for oligo- and anuric
patients (Chou & Kalantar-Zadeh, 2017). Extracellular fluid volume (EFV) from the extracellular space is mainly
the source of net UF during HD (Jeong, Lim, Choi, & Oh, 2016) or haemodiafiltration (HDF) (Tapolyai et al.,
2014) regardless of a patient’s hydration status. HDF is another form of blood purification along with a
component of UF and has been shown to have an improved solute clearance over HD, especially for middle
molecules (Locatelli et al., 2010). Although HDF has shown to be superior over HD with regards to solute
clearance, and may be used as a novel treatment option in some satellite HD clinics in WA, none of the
patients in this study received HDF as it was not the routine standard of care at the clinics of this study.
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Traditionally, all renal clinicians, doctors and nurses aim to accurately assess haemodialysis patients on excess
fluid to achieve safe treatment goals of fluid removal. Assessing extracellular fluid and determining the
treatment regimen to achieve euvolemia has been described as one of the biggest challenges for nephrologists
(Ishibe & Peixoto, 2004). Fluid assessment is one of several major responsibilities of renal nurses when caring
for patients with ESRD (Chamney, 2007). This is of particular importance to provide a safe and uneventful
treatment, as renal nurses initiate every treatment session. Generally nurses predominantly perform a predialytic fluid assessment and local policy will dictate if nurses or doctors may decide on subsequent goals of
fluid removal (Mahon et al., 2013). This means that it is highly likely that renal nurses carry substantial
responsibility in the ongoing care and management of patients when observing individual patients for fluid and
weight trends. Currently, renal nurses predominantly use their clinical skills alone to assess patients with ESRD
on their level of excess fluid prior to each HD session. This mandatory predialytic fluid assessment remains a
challenge, as the renal nurse has only few objective parameters on hand to validate the clinical decision for an
individual UFG. Parameters consist mostly of clinical observations of body weight and blood pressure
measurements before, during and after HD sessions (Chamney, 2007; Meredith, Pugh, Sutherland, Tarassenko,
& Birks, 2015) and are considered representative of the current cornerstones when assessing fluid status.
Knowing that renal nursing care has a considerable impact on patient outcomes (Ludvigsen, Hermansen, &
Lindberg, 2015), it is essential that these parameters also take into account an individual’s general weight
trend, including their ideal body weight (IBW) or dry weight (Lindberg, Bäckström-Andersson, Lindström, &
Lindberg, 2013). This is usually defined as the lowest tolerated post-dialytic weight at which there are no or
minimal clinical signs or symptoms of hyper- or hypovolemia (Sinha, Light, & Agarwal, 2010). Additional
nursing observations for pre- or intradialytic symptoms like shortness of breath, peripheral oedema and
elevated jugular venous pressure (Mahon et al., 2013) are deemed to be helpful when assessing for fluid status
(Chou & Kalantar-Zadeh, 2017). Additionally, patients need to be observed for other signs of fluid overload
such as inspiratory crepitation, low oxygen saturation and/or the need for oxygen saturation as these may
indicate the onset of pulmonary oedema (Levy, 2009).These few pre-session parameters typically guide a renal
nurse in their decision-making to determine an individual UF goal (Bradshaw & Bennett, 2015). It is likely that
this UF goal is ultimately decisive for the occurrence (or, preferably, non-occurrence) of intradialytic
hypotensive episodes (Canaud & Lertdumrongluk, 2012; Stefansson et al., 2014).
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Therefore, it has been suggested that more objective and quantitative measurements are needed, and that
reliable methods to predict target endpoints for euvolemia need to be found (Wizemann, 2009) and tested
(Chou & Kalantar-Zadeh, 2017). Ludvigsen et al. (2015) have also concluded that intradialytic observational
nursing care during ultrafiltration could be improved. These authors found that some patients were exposed
to excessive UF volumes and too-rapid fluid removal leading to adverse events such as IDH. This was
particularly observed in younger dialysis patients and patients with low body weight. Applied critical thinking
and adherence to recommended maximum UF volume thresholds per hour (Flythe & Brunelli, 2011; Ludvigsen
et al., 2015) by nurses could prevent long term side effects of HD.

1.3

Definition of IDH and clinical symptoms

According to the National Kidney Foundation (NKF) Kidney Diseases Outcomes Quality initiative (KDOQI)
guidelines, S-IDH has been defined as a SBP drop of 20 mmHg or more or a decrease in mean arterial pressure
(MAP) by 10 mmHg, combined with symptoms like muscle cramps, fatigue nausea and vomiting, restlessness,
dizziness and loss of consciousness and anxiety (National Kidney Foundation Inc., 2005). Although this
definition is the most commonly used, there exists a number of other definitions of IDH which typically
combine a drop in SBP with other nursing interventions such as intravenous saline bolus administration and/or
pausing of UF (Flythe, Xue, Lynch, Curhan, & Brunelli, 2015). Other IDH definitions only focus on intradialytic
SBP evaluation, with a precondition of a SBP drop of 20-40 mmHg or nadir SBP of 90-100 mmHg (Dheenan &
Henrich, 2001; Flythe et al., 2015). Further, the combination of an SBP fall with SBP nadir of less than 110
mmHg has also been commonly accepted as a valid IDH definition (Flythe et al., 2015; Imai et al., 2006). A-IDH
has been defined as SBP lower than 100 mmHg exclusive of any clinical symptoms (Chesterton et al., 2009).
Bradshaw, Bennett, Hutchinson, Ockerby, and Kerr (2017) have described A-IDH as a decrease in MAP of 30
mmHg or more in comparison to predialytic MAP, or a MAP below 70 mmHg, also without any clinical signs.
Interestingly, another study by Zumrutdal (2013) described the symptom of transient vocal hoarseness at the
end of HD sessions as most likely to be caused from volume depletion and dialysis-induced hypotension. This
has also been described by Unver et al. (2015), suggesting that their approach of objective voice analysis could
even be used to determine IBW. Other clinical symptoms like excessive sweating and change in skin tone have
also been reported during an IDH event (Meredith et al., 2015).
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However, the present thesis used the definition for IDH based on NKF KDOQI guidelines, as this is
predominantly used throughout most present publications.

1.4

Reported prevalence rates of IDH

IDH has been described as the most common adverse event during HD and a broad range of prevalence rates
of IDH are reported in various studies throughout the literature, ranging from 5 to 93% (Awan, Shafi, Ahmed, &
Aasim, 2011; Kron et al., 2017; Rocha, Sousa, Teles, Coelho, & Xavier, 2015; Schiller, Arramreddy, & Hussein,
2015). Some studies also report a high variability within patients (0 -100 %) (Rocha et al., 2015) but most
authors report a prevalence rate of 20 to 30 % of all treatments (Rocha et al., 2015; Schiller et al., 2015).
Typically, IDH events occur more frequently in the elderly, female and diabetic patients with higher Body Mass
Index (BMI), higher UF goals and predialytic hypotension (Schiller et al., 2015). Patients with larger interdialytic
weight gains (IDWG) are also more often affected (Awan et al., 2011), while it is traditionally assumed that
weight gain between sessions is usually being equivalent to fluid gain (Lindberg & Ludvigsen, 2012) (1g ≈ 1ml).
This is also confirmed in a study by Schulz et al. (2007), where fewer episodes of IDH in patients with IDWG <
1.5 kg/2 days were described. Importantly, an IDWG <1 kg/2 days was described as being advantageous for
survival with the lowest risk of death (Chou & Kalantar-Zadeh, 2017).

1.5

Potential causes and treatment of IDH events

Prior to a regular HD session, a renal nurse calculates an individual fluid removal in millilitres (UF goal) for the
present treatment. This is based mainly on the bodyweight gain of the patient since the last treatment, the
current blood pressure and the clinical condition observed by the nurse. This UF goal calculation is based on
the assumption that this increase of bodyweight represents excess fluid which would have been normally
excreted by the kidneys. This calculated UF goal will then be entered into the HD machine and the patient will
be connected via two cannulae and an extracorporeal blood circuit onto the machine. The HD machine
subsequently gradually removes the pre-set volume of fluid from the patient’s blood during treatment by
negative (hydrostatic) pressure in the dialyser, an artificial blood filter, which removes fluid and metabolic
substances. Over 4 to 5 hours it is expected that the patient achieves the calculated fluid volume removal
upon cessation of the session without clinical complications and is able to leave the satellite dialysis clinic in a
stable physical condition (Mahon et al., 2013). Rapid elimination of osmotic active substances, mainly urea and
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sodium, in combination with delayed re-filling from the intracellular space along with intravascular volume
depletion caused by UF may predispose patients to develop IDH (Mc Causland, Brunelli, & Waikar, 2013). This
model is supported by the fact that intravenous administration of hypertonic glucose or hypertonic saline
improved intradialytic blood pressure decline and correlated symptoms (Canzanello et al., 1991). Multiple
authors have described the same mechanism, in that IDH is a direct consequence of an imbalance between
passive plasma re-filling and excessive intravascular fluid removal (Agar, 2016; Bossola et al., 2013; Davenport,
2006). Sherman (2002) supports this theory in that IDH is rare when no UF is performed during a HD session.
Another important factor during the development of an IDH event is the UF rate (UFR). The UFR is expressed
as the amount of UF per hour (in ml/hr) occurring for an individual during HD. High UFR’s (> 10 ml/kg/hour)
have shown to be correlated with IDH, morbidity and mortality (Flythe & Brunelli, 2011; Hussein, Arramreddy,
Sun, Reiterman, & Schiller, 2017). Agar (2016) proposed that an extended treatment time would allow for
additional time to remove excess fluid safely, especially in patients with large IDWG. He also emphasised the
importance of an individual UFR ≤ 10 ml/kg/hour and a maximum UFR of 13 ml/kg/hour to reduce risk.
However, it is not unlikely that other multiple factors contribute to the formation of an IDH event. Intradialytic
food intake, especially during increased treatment times, incorrect IBW, patient characteristics, dialysate
composition and temperature, and autonomic nerve dysfunction may play an additional role (Roberts, Anne
Kenny, & Brierley, 2003; Sherman & Kapoian, 2011). Other contributing risk factors for IDH such as cardiac
dysfunction, hypoalbuminemia, underestimated IBW and antihypertensive medication have also been
identified (Berger & Takala, 2016; Chao, Huang, & Yen, 2015; Charra, 2007; San Miguel, 2010).
S-IDH and A-IDH can also be caused by an UF goal being set too high as well as being achieved too fast, and it
can be managed by adjusting the UF goal on the dialysis machine and administering IV saline (Hayes & Hothi,
2011). Current conventional therapy of an acute IDH event comprises of pausing UF or decreasing the UF rate,
reducing the blood flow rate, positioning the patient in Trendelenburg position and, in severe cases, even a
premature cessation of the treatment (Bayya, Rubinger, Linton, & Sviri, 2011; Stefansson et al., 2014).
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1.6

Clinical outcomes of IDH events

When occurring repeatedly, IDH episodes during HD have harmful effects on multiple organ systems and are
considered to cause morbidity and increased mortality for patients with chronic kidney disease (Henderson,
2012). There is sufficient evidence to conclude that both S-IDH and A-IDH qualify as an ischaemic insult to
organs (Bradshaw & Bennett, 2015; Daugirdas, 2015; Davenport, 2015). IDH adversely affects a variety of vital
end organs including the brain, gastrointestinal tract and the heart, causing a decline in residual kidney
function as well as cardiac stunning and ischemic brain injury (Huang, Filler, Lindsay, & McIntyre, 2015;
McIntyre & Goldsmith, 2015). IDH has been linked to vascular access thrombosis (VAT)(Chang et al., 2011),
insufficient dialysis dose with reduced metabolic clearance due to repeated prematurely cessation of HD
sessions (Jepson, 2009) and has a negative effect on the quality of life of these patients (Ghaffar & Easom,
2015). Eldehni and McIntyre (2012) have described ischemic brain injuries which were likely due to recurrent
circulatory stress from multiple IDH episodes, subsequently causing cognitive impairment with major
consequences not only for the patient’s quality of life, but also for their survival. Similarly, the effects of IDH
events on the cardiovascular system have been described, resulting in arrhythmias, myocardial ischemia,
infarction, stroke and cardiovascular death (Flythe, Kimmel, & Brunelli, 2011; Movilli et al., 2007). IDH has
been identified as an independent risk factor for two-year mortality in HD patients (Shoji, Tsubakihara, Fujii, &
Imai, 2004). Left ventricular hypertrophy has been described in nearly three-fourths of chronic dialysis patients
and cardiac structural changes have already occurred during early renal function impairment, so the condition
may only worsen after dialysis is initiated (Chao et al., 2015).

1.7

Intradialytic fluid assessment methods

Traditionally, intradialytic blood pressure (BP) measurements combined with patient observations on fluid–
related signs and symptoms (as described in the NKF-KDOQI guidelines) are the most usual intradialytic fluid
assessment method routinely applied worldwide by renal nurses (Germain et al., 2017). Assimon and Flythe
(2015) have stated that BP measurements are a fundamental part of monitoring patient safety during HD and
have critical clinical and prognostic significance. As intradialytic BP fluctuations with IDH are common and
renal nurses are responsible for preventing harm to their patients through preventative measures, it has been
recommended that BP measurements in 15-minute intervals are superior over longer time intervals to prevent
intradialytic complications (Horkan, 2013). A study by Roberts et al. (2003) underscored how important post-
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dialytic blood pressure measurements were to prevent patients from postural hypotension and subsequent
episodes of falls, especially in the elderly patient. A survey by Bradshaw, Ockerby, and Bennett (2015) amongst
Australian and New Zealand nurses revealed that they considered the systolic blood pressure as the most
important indicator for a deteriorating HD patient. These authors also suggested that because of the nature of
longstanding care for HD patients and knowing their specific BP threshold, renal nurses might be more aware
of an individual patient’s circumstances and could potentially predict when they become hypotensive.
Bradshaw et al. (2017) have further emphasised the importance of measuring and monitoring the MAP, as it
could serve as an early indicator for A-IDH. These authors suggested that using the lowest tolerable threshold
of 70 mmHg or a fall in MAP of 30 mmHg compared to predialytic MAP could be used to predict an imminent
episode of IDH. Subsequent pausing of UF could be used to avoid the occurrence of IDH and also allow for
continuation of the treatment (Bradshaw et al., 2017). What is clear is that BP measurements for assessing
fluid status in HD patients certainly have their limitations.
Further, Van Buren and Inrig (2017) have described a group of HD patients where intradialytic BP increased
despite ultrafiltration taking place. These authors have described an unexpected chronic phenomenon,
intradialytic hypertension, which occurs in almost every HD patient occasionally and may occur recurrently.
They also identified this underreported subgroup of patients for an exceedingly high risk of morbidity and
mortality. A study by Wabel et al. (2008) revealed that in almost a quarter of their HD patients there was no
correlation between hypertension and hypervolemia. Similarly, Khan, Sarriff, Adnan, Khan, and Mallhi (2017)
found 22% of their study population was hypertensive but euvolemic, while 12% were normotensive but fluid
overloaded. These facts underscore the fact that renal nurses should not rely solely on BP measurements as an
indicator for fluid status.
Blood volume monitoring (BVM) is another method that can be used by renal nurses to observe a patient’s
intradialytic progress in fluid removal (Damasiewicz & Polkinghorne, 2011). BVM devices use light to
constantly measure intradialytic haematocrit and haemoglobin values, displaying an overall trend for the
circulating relative blood volume (RBV). They are supposed to indicate a specific threshold when UFR exceeds
passive plasma-refilling (Damasiewicz & Polkinghorne, 2011) and indicating an imminent episode of IDH. While
some studies advocate the use of BVM devices to prevent patients from IDH (Saxena, Sharma, Gupta, & John,
2015), others see its use in a critical light and suggest that its use must be combined with the nurses’ critical
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thinking skills to be effective (Micklos, 2013). Ibrahim and Taweel (2007) claim that assessing intradialytic
changes in plasma for estimation of hydration status is not useful. Although BVM may be used frequently in
HD units elsewhere, it is a piece of equipment which does not exist in the clinical areas where this research
took place, and therefore is beyond the scope of this thesis.
Another method to approximate fluid status is bioimpedance spectroscopy (BIS). This technique measures
conductivity in body tissue in response to a small bioelectrical current (Earthman, Traughber, Dobratz, &
Howell, 2007). While this current is conducted well by water and tissues containing electrolytes (e.g. muscles
and blood), there is poor conduction by fat, bone and air-filled areas and has the potential to cause inaccurate
readings. The Body Composition Monitor (BCM, Fresenius Medical Care, Bad Homburg, Germany) uses
multifrequency bioelectrical impedance analysis (MFBIA) to detect fluid overload and to determine the
patient’s overall fluid status (Machek, Jirka, Moissl, Chamney, & Wabel, 2010; Wizemann, 2009). It has
limitations and should not be used in patients with implanted pacemakers, defibrillators or cochlear implants
(Wabel et al., 2008). Further, although indicating EFV, it cannot discriminate between extravascular and
intravascular volume, whereas in HD the critical value for the definition of an UF goal aiming for a stable
treatment without IDH events is the intravascular fluid status (Jaeger & Mehta, 1999). Based on this,
Davenport (2013) claimed that exact intravascular volume assessment in HD patients remains vital to prevent
patients from both IDH and from hypervolemia. However, Davenport (2013) also warned that using this tool to
reduce IBW aggressively while not knowing the intravascular fluid status could potentially cause a prematurely
loss of residual urine output function, a disaster for a patient with ESRD. Although BIS was available in one of
the dialysis units during this project, this device was not regularly used as part of a nursing routine for fluid
assessment. A national survey amongst dialysis clinics in the United Kingdom (UK) in 2016 revealed that only
27% of the dialysis clinics were using BIS and only 38% felt that fluid management was adequate (Dasgupta,
Farrington, Davies, Davenport, & Mitra, 2016). A vast majority (77%) of surveyed dialysis clinics felt there was a
need for better evidence in fluid assessment and 91% would participate in a study addressing this issue
(Dasgupta et al., 2016). These survey results underscore the urgency and importance of the substantive
problem for improved accuracy of fluid assessments in haemodialysis patients.
In contrast to BIS, Simoni, Vitturi, and Dugo (2016) have stated that the IVC most accurately reflects the
intravascular part of body fluid volume. Usually, the systemic circulation of a healthy adult holds 84% of the
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total blood volume and 64% of this is pooled in the venous system (Hall, Guyton, & Ebook, 2011). Although it
might vary with different states of venoconstriction and dilatation, it indicates the importance of the venous
blood system for the assessment of intravascular volume status. Veins serve as a blood reservoir for blood
circulation, and the inferior vena cava represents the largest venous vessel in the human body (Hall et al.,
2011). Therefore, clinicians have considered the measurement of the IVC for intravascular volume assessment
in patients, assuming that either a collapsed or distended state could be reflective of venous filling (Chen, Kim,
& Santucci, 2007). Lyon, Blaivas, and Brannam (2005) have demonstrated that IVC-US is a reliable indicator for
blood loss, even for small volumes (e.g. 450ml), and they suggested it could be helpful when assessing
potential volume depleted patients. Further, IVC-US has been demonstrated to be a useful method to evaluate
the volume-status of a HD patient (Brennan et al., 2006). The IVC diameter (IVCd) is indicative of the circulating
blood volume during and after HD and ultrasound could provide non-invasive real-time information about
blood volume which correlates with central venous pressure (CVP)(Tetsuka, Ando, Ono, & Asano, 1995;
Wallace, Allison, & Stone, 2010). Therefore, IVC-US could hold important prognostic value as CVP is
prominently reduced during the first hour of HD (Thalhammer et al., 2015). A study by Brennan et al. (2006)
revealed not only that IVC-US could be performed by clinicians with minimal echocardiographic proficiency,
but it also demonstrated that almost 50% of their patients were already volume depleted at treatment start
and concluded that IVC-US is an achievable option to assess the intravascular volume status in a satellite
dialysis clinic. The IVCd changes dynamically during the respiratory cycle, therefore an ultrasound
measurement of the IVC needs to be obtained during inspiration reflecting the IVC minimum diameter (IVCmin),
while a second measurement needs to be acquired at maximum expiration reflecting the IVC maximum
diameter (IVCmax). From these two measurements, an IVC collapsibility index (IVCCI) can be calculated [(IVCmax IVCmin / IVCmax) x 100] which correlates with CVP (Thanakitcharu, Charoenwut, & Siriwiwatanakul, 2013). IVCCI
calculations based on US are simple and non-invasive and could be used to monitor intravascular volume
status during slow continuous ultrafiltration and hence optimise fluid removal rates (Guiotto et al., 2010).
Another measure relevant to intravascular fluid is the indexed vena cava diameter (VCDi). This is calculated by
dividing IVCmax (in mm) by the body surface area in m2 (Cheriex, Leunissen, Janssen, Mooy, & Van Hooff, 1989).
These two derived measurements provide a good point approximation of the intravascular volume status. The
current ‘Guidelines for the Echocardiographic Assessment of the Right Heart in Adults’ (Rudski et al., 2010)
propose that a diameter < 2.1 cm and IVCCI > 50% indicates hypovolemia correlating with venous pressure.
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IVCCI cut-offs for hypovolemia, euvolemia and hypervolemia are shown in Table 1 and VCDi cut-offs are
displayed in Table 2. Care needs to be taken when assessing VCDi as in patients with tricuspid regurgitation
caused by pulmonary hypertension or biventricular heart failure a dilated IVC may be observed, which could
be misinterpreted as hypervolemia (Yepes-Hurtado, Omar, Monzer, Alalawi, & Nugent, 2016). On the other
hand, distal IVC thrombosis can lead to a narrower IVC and could potentially be misinterpreted as hypovolemia
(Häusler, Hübner, Delhaas, & Mühler, 2001).

Table1. IVCCI cut-offs according to the ‘Guidelines for the Echocardiographic Assessment of the Right Heart in
Adults’
Volume status

IVCCI Collapsibility Index (%) = 100 (max min diameter) / max diameter

Maximum IVC diameter

Hypovolemia

> 50%

< 2.1 cm

Euvolemia

> 50%

> 2.1 cm

< 50%

< 2.1 cm

< 50%

> 2.1 cm

Hypervolemia

Table2. Indexed vena cava diameter corrected for body surface area (VCDi) cutoffs according to 'Echography
of the Inferior Vena Cava is a Simple and Reliable Tool for Estimation of 'Dry weight' in Haemodialysis
Patients'(Cheriex, Leunissen, Janssen, 1989)
Volume status

IVCCI Collapsibility Index (%) = 100
(max - min diameter) / max diameter

Indexed vena cava diameter
corrected for body surface area
(VCDi)

Hypovolemia

> 75%

< 8 mm/m2

Euvolemia

≥ 40 and ≤ 75%

Hypervolemia

< 40%

> 11.5 mm/m2

Several studies have confirmed that ultrasound-naïve clinicians can successfully be upskilled to perform and
interpret IVC-US with moderate to good agreement with an expert (Brennan et al., 2006; Fields et al., 2011;
Muniz Pazeli et al., 2014). Specialised nurses from various clinical areas such as emergency departments and
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heart failure clinics have used IVC-US with success, achieving similar results to ultrasound experts (Dalen et al.,
2015; Gustafsson, Alehagen, & Johansson, 2015). While nurses in the study from Dalen et al. (2015) had
experience performing focused ultrasound of the IVC, the nurses in the report from Gustafsson et al. (2015)
were ultrasound novices and, although specialised in their clinical area, were unfamiliar in the use of
ultrasound. These studies demonstrated that even nurses without formal ultrasound training were able to
develop a new clinical skill, which was thought to be helpful for their everyday practice and which was
considered to improve patient outcomes.
Renal nurses spend significant time with patients during their regular treatments and they make important
observations on adverse events during treatment time as part of their regular clinical practice. They are in an
ideal situation to collect additional information to improve direct patient care and to enhance knowledge of
clinical nursing. At present regular nursing care includes pre-, intra and post-dialytic patient observations and a
clinical fluid assessment prior to HD to inform a critical decision on an intended UF goal. This decision is mostly
based on very few objective parameters including systemic BP, predialytic weight, IBW and recorded data from
previous dialysis sessions. As a consequence, the occurrence of any intradialytic adverse event, which are most
commonly episodes of IDH, relates mostly to this initial decision-making process. Providing renal nurses with
another dimension of clinical information through IVC-US was considered potentially helpful. Knowledge of
intravascular volume status through direct visualisation with IVC-US could potentially inform the renal nurse to
validate the initial decision on the UF goal or reconsider further clinical measures. Generally, there is no
radiographer available in satellite HD clinics and these significant and sometimes difficult clinical decisions
must be made quickly. With IVC-US being a swift, non-invasive and focused method to assess intravascular
volume status, it is considered that this would deliver essential additional information to renal nurses. In light
of this, finding evidence in publications and exploring whether this method had been previously used by renal
nurses was an integral part of this study.
Hence, this next chapter set out to explore if renal nurses in outpatient HD clinics have previously used IVC-US
and if IVC-US was used for the purpose of intravascular fluid assessment to diagnose imminent hypovolemia
and avoid adverse outcomes for HD patients.
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Chapter 2
2.

Literature Review

2.1

Foreword

This chapter provides a published review of the literature between 1996 and 2015 and then updated literature
since publication (see section 2.2). It evaluates the existing scientific literature with regard to the use of
ultrasound by nurses in a broad variety of clinical specialities and in particular whether renal nurses have
successfully used IVC-US for the purpose of intravascular volume assessment. Multiple studies have identified
that IVC-US used by healthcare professionals is a swift and non-invasive method when assessing HD patients
for intravascular volume (Brennan et al., 2006; Thanakitcharu et al., 2013). Finding scientific evidence to
identify the previous use of IVC-US by renal nurses was essential prior to the start of this research project.
The PRISMA statement for reporting a systematic literature review was chosen to demonstrate rigor and to
obtain objective and reliable results. Multiple medical and nursing databases were examined for relevant
content to aggregate significant information with the potential to answer the primary research question. The
intention of this approach was to first identify multiple research studies and scientific publications, critically
analyse the quality of their content and then present the combined findings.
These findings were important for this research project, as renal nurses are responsible for ongoing clinical
observation during an individual treatment session, but also for the critical decision of the UF goal prior to
treatment initiation. Renal nurses in satellite HD clinics in WA have generally no medical backup available and
must decide on UF goals on their own, based on their assessment of the patient and on their own knowledge,
skill and experience. This decision, generally based on several clinical parameters such as assessing a patient’s
general fluid status, IBW and predialytic BP readings, has significant potential to influence patient outcomes
during and directly after their session. Hence, it is postulated that IVC-US could potentially deliver important
additional objective information for this initial decision-making process and help the renal nurse to reconsider
UF goals.
The following article has been published in the journal ‘Journal of Renal Care’, Sep 2017
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Pages 21-31 are not available in this version of the thesis as it includes the article:
Steinwandel U., Gibson N.P., Rippey J.C., Towell A., Rosman J. (2017). Use of ultrasound by
registered nurses—a systematic literature review. Journal of Renal Care 43(3), 132–142. doi:
10.1111/jorc.12191 https://doi.org/10.1111/jorc.12191.
An Open Access version of the article is also available at: https://ro.ecu.edu.au/ecuworkspost2013/3268/

2.2

Additions to the systematic literature review (from 2015 to 2017)

The quality appraisal of articles used in this preceding published article was based on the recommended
methods of the PRISMA Statement (Moher, Liberati, Tetzlaff, & Altman, 2009). Minimum requirements for
inclusion of published literature in the systematic literature review were peer-reviewed articles including an
abstract and full-text articles with available references.
The following section describes and summarizes further details of peer-reviewed scientific publications, which
describe recent findings of experts in the area of intravascular volume assessment using a variety of different
approaches and methodologies.
Since publication of this systematic literature review (Steinwandel, Gibson, Rippey, Towell, & Rosman, 2017)
new knowledge has emerged on the use of ultrasound and other technical methods for intravascular volume
assessment. Chou, Kalantar-Zadeh, and Mathew (2017) have highlighted the importance of clinical studies to
determine objective intravascular volume correlating with IDH and the need for scientific findings where
interventions could be cost-effective and beneficial. Inaccurate fluid assessment by clinical staff before and
during a HD session are associated with chronic fluid overload and poorer health outcomes for HD patients
(Chou & Kalantar-Zadeh, 2017). These authors also stated that additional methods, like IVC-US and BIS
amongst other methods, might deliver objective results for volume status, but may carry the risk of being
erroneous during calibration and may vary in the operator interpretation of the findings. The crucial question
still remains, how much fluid can safely be removed with HD? (Chou & Kalantar-Zadeh, 2017). Chou et al.
(2017) have now suggested offering additional dialysis sessions to patients with large IDWG’s, so that more
frequent or even nocturnal HD reduces the risk of myocardial stunning.
Other forms of ultrasound techniques to assess HD patients for fluid have recently been successfully used.
Lung ultrasound (LUS) on HD patients revealed a strong correlation with fluid removed from patients and a socalled reduction in B-lines (Jiang, Patel, Moses, DeVita, & Michelis, 2017). B-lines are sonographic findings
depicting pulmonary interstitial oedema and can be detected by LUS (Jiang et al., 2017). The reduction of
detected B-lines correlated with intradialytic fluid loss in their study. Hence, LUS was described by these
authors as a helpful tool to achieve a more accurate IBW, providing precise information on adequacy of fluid
removal.
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Although published prior to 2015, an important finding in regards to shape of the collapse of the IVC had been
presented by Naruse, Sakaguchi, Nakayama, Nonoguchi, and Tomita (2007) when assessing a HD patient for
fluid. These authors postulated that individual IVCd’s differed in shape and while most people had a horizontal
ellipse in IVC, some others had a vertical shaped IVC. The shape of collapse of the IVC, either horizontal or
vertical, needs to be taken into account and it was shown to be more accurate when calculated as an IVC flat
ratio, which correlated well with fluid status.
Another essential study by Dietel, Filler, Grenda, and Wolfish (2000) had revealed a good correlation between
BIS, IVCd and fluid status in paediatric HD patients. They suggested combining both methods as an adjunct for
post-dialysis assessment for dry-weight.
An observational, retrospective study by Sangala, Gangaram, Atkins, Elliot, and Lewis (2017) concluded that
delta SBP is useful for the prevention of IDH. Delta SBP is calculated with the following formula [ (pre SBP –
post SBP)/pre SBP x 100] and could be used to identify patients most at risk for IDH. According to these
authors, delta SBP is expressed as a ratio and varies with hydration status. They further described that an
increase in hydration status consequently reduced IDH symptoms and delta SBP and concluded that a
reduction in hydration status is associated with an increased risk of IDH along with an increase of delta SBP.
Recently, the BISTRO study has been initiated to determine if the use of BIS to guide IBW decisions in novice
HD patients, with a minimum of 500 ml residual urine output, will have a positive effect on patient outcomes
and could preserve residual urine output (Davies et al., 2017). Results of this study could potentially lead to
recommendations for using BIS on a broader scale, especially having more objective parameters on hand to
guide clinical decision making. Similarly, a study by Siriopol et al. (2016) aimed to compare head-to-head BIS
and LUS on their predictive value of all-cause mortality. This study found that fluid overload measured by BIS,
but not LUS, improved risk prediction for death. Following this, another study by Siriopol, Siriopol, Voroneanu,
and Covic (2017) has demonstrated that the combination of BIS and brain-type natriuretic peptide (BNP) in
diagnosis of fluid overload led to a more comprehensive fluid evaluation and could improve patient outcomes.
A mandatory pay-for-performance ESRD Quality Incentive Program (QIP) in the United States (US), introduced
in 2012, linked Medicare payments to dialysis providers performance on recommended quality methods
(Flythe, Assimon, & Overman, 2017). Following this, the National Quality Forum (NQF) endorsed the UF rate
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measure in 2015, intending to support balance between overzealous and too conservative fluid removal. To
achieve this, the UFR needs to be limited either with the extension of treatment time or lowering of UF
volumes (J. E. Flythe et al., 2017). Their study showed the significance of an extracellular fluid measure in
outweighing an UF rate measure, especially as in the US, HD treatment times are markedly shorter than in the
rest of the world (J. E. Flythe et al., 2017). These authors highlighted the importance of identifying and
validating objective measures of volume status in the future to enable more informed approximation and
prescription of IBW, thus preventing patients from harm caused by forceful fluid removal. Flythe, Assimon, and
Wang (2017) have also underscored the importance of always questioning and reconsidering accepted
standards, and never allowing complacency to lead to the belief that existing standards equate with best
practice.
Valtuille (2017) has described IVC-US as a safe and cheap technique that can be performed at the patient’s
bedside, but has also described IVC-US as an operator-dependent technology and supervised training is
essential for the correct interpretation of findings (Basso et al., 2013). Valtuille (2017) suggested using BIS as a
routine bedside clinical tool to help for decision-making processes of health care professionals.
A literature review by Zhang and Zhao (2017) revealed reliability and accuracy of IVC-US for volume
assessment, but recommended that the interpretation of results should be by physicians with acceptable
understanding of underlying physiological changes. They also described a failure rate of almost 15% for IVC
visualisation due to the occurrence of increased subcutaneous fat tissue and bowel gas, limiting its use in
obese patients. This may affect HD some patients, as they generally have to use oral phosphate binders which
have abdominal bloating as a common side-effect (Chan et al., 2017).
With regard to technique, the best practice for mode and view of the IVC with point-of-care ultrasonography
(POCUS) was assessed in a study by Finnerty et al. (2017). It was revealed that the sub-xiphoid transabdominal
long axis (LA) in B-mode held the best promise in delivering reliable dimensions of IVCd and had the highest
interrater reliability (IRR) compared to M-mode and transabdominal short axis (SA) or right lateral
transabdominal coronal long axis. These findings corroborate the decision to use only LA and SA
measurements for all IVC-US measurements in our research project.
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A comparison between BIS and echocardiographic fluid assessments in HD patients by Cristina Di Gioia et al.
(2017) revealed that the left atrial volume index evaluated by echocardiography correlated with BIS.
Moreover, a meta-analysis by Covic et al. (2017) reviewed seven randomised controlled trials (RCTs) where BIS
was used to assess IBW and fluid status compared with standard assessment methods. This meta-analysis
showed that BIS-based IBW assessment had no statistical significant effect on all-cause mortality in ESRD, but
indicated that BIS could improve BP control and overall overhydration. It was recommended that larger studies
combining BIS with other methods like LUS could be useful for IBW assessment in ESRD patients (Covic et al.,
2017).
Alexiadis et al. (2017) compared multiple fluid assessment methods, including LUS, BVM and BIS in HD patients
with IVC-US, using IVCd as the baseline reference method for all other methods. LUS indicated the most
promising results in predicting overhydration compared to reference values of IVCd measured by IVC-US.
Therefore, these authors concluded that LUS should be considered as a useful method to assess fluid status
and evaluation of IBW. Conversely to this study, Sabaghian, Hajibaratali, and Samavat (2016) used BIS as the
reference method to evaluate the best echocardiographic marker of volume status in HD patients. They found
that IVCdimin (indexed minimum inferior vena cava diameter = IVCmin/BSA) showed the best correlation with
hydration status prior to HD, compared to other indices like IVCd or IVCdimax (indexed maximum inferior vena
cava diameter = IVCmax /BSA). The Body Surface Area (BSA) is defined as the measured or calculated surface
area of the human body and is usually calculated with the Du Bois formula. (BSA (in m2) = 0.007184 x body
weight 0.425(in kilograms) x body height 0.725 (in centimetres). These authors have therefore recommended the
use of IVCdimin as a good parameter for assessment of the volume status of HD patients.

2.3

Conclusion

In summary, recently emerged literature compared a variety of additional objective fluid assessment methods
and parameters including BVM, BIS, BNP, LUS and IVC-US, however none of these were specifically used by
renal nurses. All these methods were applied in a variety of combinations to validate their accuracy and assess
correlation with clinical signs of excess fluid. These studies underscored the general need for more reliable and
accurate information about volume status to ultimately reduce intradialytic and immediate post-dialytic
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adverse events. Several reports described a wider use of ultrasound techniques, particularly LUS, and this
relatively novel method was also compared to IVC-US to evaluate excess fluid.
Multiple features of IVC-US technique have been shown to be favourable over other methods. Alexiadis et al.
(2017) highlighted several aspects where IVC-US was a technique that provided critical accurate and reliable
information. They argued that IVC-US was safe because it was radiation-free, simple and comparably
inexpensive. These authors outlined further that skill acquisition of the IVC-US technique should be easy and
could be done at the bedside. Additionally, they highlighted a significant difference when comparing LUS with
IVC-US. LUS may only be able to indicate information on overhydration, as the minimum B-Line score was 0
(no oedema). It could therefore be difficult to depict hypovolemia with LUS, which is a common adverse event
in HD patients. In view of this fact, LUS was not considered appropriate for comparison in this study as the
focus of this thesis is mainly concerned with IDH, an adverse event associated with hypovolemia. However, as
the most commonly mentioned and validated reference method was BIS, this was chosen in this study as a
comparator to IVC-US in order to demonstrate their usefulness and validity against traditional clinical
assessment methods.
IDH has been described as the most common adverse event during HD, but reported prevalence may vary
depending on numerous contributing factors. These may include different approaches for IDH prevention
locally and globally. Additionally, there may exist a broad variety of dialysis unit-specific policies and
procedures regarding clinical fluid assessment and fluid removal, including diverse fluid assessment
methodologies. In view of this, it was necessary to evaluate the magnitude and scale of IDH in the project
population, and to this end a retrospective observational study was performed in a local satellite HD clinic,
measuring the prevalence of IDH events.
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Chapter 3
The prevalence rate of Intradialytic hypotension
3.1

Introduction

This chapter aims to describe the prevalence rate of IDH in a satellite HD clinic in the wider Perth metropolitan
area, in order to explore the magnitude of the problem of IDH at the local level.
Daugirdas (2015) has recommended tracking IDH events to help dialysis care providers evaluate the success of
quality improvement activities, with the aim of reducing incidences of IDH. This part of the research project
also aimed to identify the proportion of both S-IDH and A-IDH to demonstrate their true frequency. This phase
of the study was of particular interest as A-IDH may often be underreported due to its asymptomatic nature.
As described earlier, various definitions for A-IDH exist and for the purposes of this study we used the
commonly accepted definition according to the National Kidney Foundation (National Kidney Foundation Inc.,
2005), defined as a drop in SBP of at least 20 mmHg from baseline.
Due to a broad variety of clinical definitions for any form of IDH, there is also a broad range of prevalence rates
being reported in the literature (Flythe et al., 2015). Combined prevalence rates of IDH ranging from 15 to 50%
of all HD sessions are reported (Flythe et al., 2015), but generally a prevalence rate of 20 -30% has most
commonly been reported (Rocha et al., 2015; Schiller et al., 2015). Individual figures at a local level may also
vary widely, depending on a variety of factors. Firstly, there may be geographical differences in the way
ambulatory HD was delivered. Secondly, some of the data reported may have preceded any recent
preventative measures including quality improvement activities that might have been implemented at a local
level. Thirdly, patient-staff ratios, nursing staff levels, the level of their individual renal-specific education, and
facility-specific practices may play significant roles when comparing facilities delivering HD care and the
occurrence of IDH. Although likely to be of influence, these factors were beyond the scope of this thesis and
hence were not explored in the modelling described in this chapter but remain a potential focus for future
research.
As IDH has been described to not only affect the quality of life of HD patients but also to be harmful to various
organ systems (McIntyre & Goldsmith, 2015), this study aimed to accurately record the quantity and scale of
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both IDH and OH events over an extended time period of 3 months. Reporting these figures, including the
description of characteristics of individuals mostly affected by IDH, was considered to be informative and
provided valuable insights in preparation for this research project. It is expected that results from this chapter
may provide essential data to inform current nursing practice, and may direct clinicians to reconsider and
potentially improve their current clinical approach in predialytic fluid assessment. It is postulated that this
could generally involve the use of a wider array of objective fluid assessment methods, including IVC-US
and/or BIS for the prevention of IDH.
The following article has been published in the journal ‘Journal of Clinical Nursing’ on the 15th February 2018.
https://doi.org/10.1111/jocn.14309

38

Pages 39-48 are not available in this version of the thesis as it includes the article:
Steinwandel, U., Gibson, N.P., Towell, M., Parsons, R., Rippey, J.C.R & Rosman, J. (2018).
Measuring the prevalence of intradialytic hypotension in a satellite dialysis clinic: Are we too
complacent? Journal of Clinical Nursing, 27, e1561-e1570.
https://doi.org/10.1111/jocn.14309
An Open Access version of the article is also available at: https://ro.ecu.edu.au/ecuworkspost2013/4266/

Chapter 4
4.

The educational programme for renal nurses to perform IVC-US

4.1

Introduction

The previous chapter has indicated that IDH episodes occur frequently in local satellite dialysis clinics and that
UF goals are occasionally overestimated. Previous research has demonstrated that IVC-US may be a helpful
addition when assessing fluid status and that medical residents with no prior official ultrasound training were
able to acquire this skill (Brennan et al., 2006). In Brennan’s 2006 study, physicians undergoing limited training
were able to obtain high-quality pictures almost comparable to those of experienced sonographers. However,
IVC-US measurements are user-dependent and bowel gas may affect the visibility of the IVC in some patients
(Dou, Zhu, & Kotanko, 2012).
The clinical skill set of renal nurses usually does not include IVC-US for intravascular volume assessment.
Historically, some renal nurses may have received theoretical and practical training in the use of ultrasound to
assess arteriovenous fistulas of HD patients (Marticorena et al., 2015). Therefore, for some renal nurses they
may now have a basic understanding of practical ultrasound skills. However, for renal nurses to acquire skills in
the specific area of objective volume assessment in patients using IVC-US, there is need to establish and
provide further education.
To achieve this, a comprehensive educational programme was designed and created in collaboration with an
expert sonologist from the emergency department of a local, large tertiary hospital. A sonologist is a medical
doctor who performs ultrasound scans and uses their cognitive and radiographic skills to make the diagnostic
determination at the time of the bedside application of focused ultrasound (Stawicki & Bahner, 2015). The
clinical experience of the sonologist was deemed to be the fundamental prerequisite for adequate guidance
and clinical direction in this project, as this expert provided the required theoretical and practical support.
Tailoring the educational programme to the specific needs of renal nurses, and focussing the POCUS on a
specific anatomical area so that they could acquire a particular skill, was one of the major challenges during
this design process.
The structured educational programme was created following the theoretical framework by Benner (1984),
which describes five stages in the acquisition and development of a skill for a nurse until finally clinical
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competence can be achieved. In the first stage, where the novice has no experience in situations in which they
are expected to perform, the nurse lacks confidence and cannot demonstrate safe practice while continuous
support is needed. In stage two, as an advanced beginner, the nurse demonstrates marginally acceptable
performance and developing knowledge, while in stage three competency is achieved, through repetition and
demonstrated efficiency and a task can be completed within a suitable time frame without external support.
Benner (1984) then continues to describe the stage four where the nurse becomes proficient, perceiving
situations as a whole and achieving finally stage five, the last stage, where a nurse becomes an expert. In this
last stage an expert nurse is more guided by an intuition and has a deep understanding of the total clinical
situation. This framework was deemed to be a relevant model for contemporary renal nursing practice as
nursing in the acute care setting has grown increasingly complex and there is a need for highly experienced
nurses who use efficiently their resources. Furthermore, nurses have presently a higher responsibility than in
the past, specifically in the ambulatory haemodialysis clinic setting where no medical staff is present and have
to make independently critical decisions with potentially significant consequences for patients.
The structured programme consisted of four modules (theory, observation, demonstration and assessment).
The programme was delivered in a stepped approach, so that the renal nurse was able to refine the practical
skills of IVC-US at an individual pace. A critical element for the success of this programme was module 3
(demonstration), during which the renal nurse had to perform 100 proctored scans, the first 30 under direct
supervision by the expert, then 70 independent and self-directed scans to refine skills and image-acquiring
techniques. These 100 scans, although performed independently, were recorded and reviewed post-hoc by
the sonologist to ensure validity and accuracy. Despite being the most time-consuming component of the
research project as a whole, this phase was an important and integral part, given the potential for renal nurses
to achieve competency in a new clinical skill. Another important element of this programme was the ability of
the renal nurse to successfully highlight the major differences between the aorta and the IVC, as their diversity
has previously been described as confusing (Zhang & Zhao, 2017). The incorrect identification of these vessels
could have significant negative consequences on the expected learning outcomes and ultimately patient care.
Overall, this programme has good potential to be successfully used by other clinicians in similar clinical settings
and may be used in future by clinical educators to develop the skills for renal nurses for the same purpose.
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This following article explains in detail the four-module education program devised for renal nurses in the skill
of IVC-US and has been published on the 24th July 2018 in the Renal Society of Australasia Journal.
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Chapter 5
Assessing nursing competency in volume assessment using IVC-US
5.1

Introduction

The final step of the education programme consisted of a competency assessment of the nurses’ ultrasound
skill validated independently by two sonologists. The mandatory number of 100 scans was decided in
collaboration with the expert sonologist, who confirmed that this number of repeated scans should be
sufficient to ultimately achieve competency in the skill of IVC-US. After completing 100 preliminary scans,
firstly 30 supervised and then 70 independently performed by the renal nurse on a broad variety of HD
patients, the renal nurse then performed and recorded 60 additional scans on a group of 10 patients without
any direct supervision. During this phase of the project it was assumed that the renal nurse was now capable
of performing routine IVC-US scans and to master the practical skill of high quality image acquisition. The renal
nurse obtained scans on each individual of two different views of the IVC, one in longitudinal and one in
transverse view, at the commencement, halfway and end of the dialysis session. Results of the second
(transverse scan) of the paired scans was expected to confirm the finding of the first (longitudinal) scan,
potentially supporting clinical findings.
Following this, the findings were assessed independently by two sonologists. As expert raters, the sonologists
firstly assessed each single scan on image quality and then classified intravascular volume status into three
different categories: hypovolemic, normovolemic and hypervolemic. All raters were blinded to each other’s
results, so their rating results could be independently compared.
Achievement of competency of the skill IVC-US for the renal nurse was an important milestone and a key
element in this research project, as it allowed for further independent assessment of patients prone to
episodes of IDH in the final simulation phase of this research project. The renal nurse, which was the
candidate, has had 18 years’ work experience in haemodialysis in a broad variety of clinical settings in Europe
and Australia prior to the learning of the IVC-US skill and also holds a qualification as a Nephrology Nurse at a
Masters level.
The following article describes the evaluation process of the IVC-US skills of the renal nurse by two
independent sonologists. A STROBE checklist for cross-sectional studies was used for the reporting of the study
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results of this observational study. This article has been published in “Hemodialysis International” (2017), DOI:
10.1111/hdi.12606
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Chapter 6 is not included in this version of the thesis.

Chapter 7
7.

Discussion

7.1

Introduction

This discussion chapter will explore the major findings from this thesis. Significant results of the five published
articles will be considered, including the potential impact on current renal nursing practice and the capacity to
inform policy and future research.

7.2

Overview of major findings

Results from each phase of this research project have provided findings that informs the initial research
questions. These findings have provided important information and provide a better understanding of the
issues regarding objective fluid assessment with different methods, prevalence rates of IDH and the usefulness
of IVC-US in comparison with other objective methods.

7.2.1

IVC-US as a tool for renal nurses

The initial systematic literature review revealed that IVC-US could potentially assist in the setting of UF goals,
has potential to reduce the risk of IDH and could change current nursing practice when added to clinical
nursing assessment. Current standard fluid assessment methods by renal nurses are lacking in accurate and
objective parameters for the determination of specific and safe UF goals. No previous peer-reviewed literature
was identified where renal nurses used IVC-US, but it was found that this technique was already being applied
by other nurses in other clinical areas. These studies indicated that nurses in a variety of clinical settings were
able to learn and apply this practical skill and that the transfer of this aptitude could be successful. It has been
shown that nephrologists with little ultrasound training have demonstrated satisfactory performance of IVCUS and have reached excellent and substantial agreement when their results were compared to those of a
cardiologist trained in its use (Muniz Pazeli et al., 2014). Other nurses, in a variety of clinical settings such as
emergency departments and heart failure clinics, have also achieved results comparable to ultrasound experts
(De Lorenzo & Holbrook-Emmons, 2014; Gustafsson et al., 2015). These studies have shown that the skill of
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the operator was the deciding factor for the success of the measurement, rather than the occupation of the
operator (Dalen et al., 2015; De Lorenzo & Holbrook-Emmons, 2014; Muniz Pazeli et al., 2014).
Additionally, the review has indicated that IVC-US could be an effective measure in recognising volume related
hypotension. Therefore, IVC-US performed during HD could be used to anticipate episodes of hypotension and
should have minimal side effects on the patient. Hence, it was hypothesised that renal nurses should be able
to use IVC-US for pre- and intradialytic volume assessment in satellite haemodialysis clinics after adequate
training had been provided. The nurse would then be able to use this additional skill to diagnose imminent
intradialytic hypotension, intervene clinically and avoid adverse patient outcomes.
In summary, the use of IVC-US adds an important clinical dimension for volume assessment, and the
intravascular volume status could be monitored directly, swiftly and at any time during dialysis. This real-time
visual impression of an individuals’ intravascular volume status could also potentially prompt renal nurses to
reconsider initial decisions on UF goals. Historically, renal nurses who initiate and perform HD sessions have
only pre- and intradialytic BP measurements and pre- and post-session weight measurements available when
assessing patients for fluid-indicating parameters. These objective parameters, in addition to clinical
observation and the nurses’ clinical experience are currently guiding them to define an individual UF goal. As
renal nurses, they have the responsibility and obligation to make critical and safe decisions at the beginning of
each treatment to ensure an event-free HD session. Given that almost a quarter (22%) of a dialysis population
can be hypertensive yet euvolemic (Khan et al., 2017), this indicates the need for an additional objective
measurement to better guide this decision-making process, which then could lead to improved patient
outcomes. The candidate has hypothesised that IVC-US may be that additional measurement.

7.2.2

The prevalence rate of intradialytic hypotension (IDH)

The extent of the IDH problem in the local renal community was formerly unspecified and this research has
contributed toward enumerating the scale of IDH. Episodes of symptomatic (S-IDH) and asymptomatic (A-IDH)
hypotension were measured in a satellite haemodialysis clinic over three months and the results highlighted
that IDH exists on a broader scale and affects more patients than is generally perceived. The phenomena of A-
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IDH has previously been described (Bradshaw & Bennett, 2015; Bradshaw et al., 2017), but its prevalence has
not yet been reported. Events of A-IDH may be generally underreported due to its latent nature and as a result
may rarely be recognised by patients or nurses. This research showed that by including episodes of A-IDH, the
total number of IDH events increased by almost a third.
Modelling also revealed that females had almost twice the risk of experiencing an event of IDH when
compared to males, and patients diagnosed with glomerulonephritis had a significantly lower risk than
patients with diabetes; phenomena both previously described in other studies (Rocha et al., 2015; Sands et al.,
2014). This could be due to a variety of additional risk factors which are highly prevalent in patients diagnosed
with diabetes such as vascular calcification and stiffness and autonomic dysfunction (Flythe et al., 2011).
Treatment duration also had a significant impact on predicting episodes of IDH, where patients with longer
treatment hours (4.5-5 hrs) had a threefold or more chance to have IDH compared to patients receiving
standard 4 hr treatments. It is possible that this increased risk correlates with the policy of generally using the
maximum UFR of 1,000 ml/hr as default for every patient in our study unit, irrespective of their IBW and
planned length of dialysis. This undifferentiated approach has been associated with detrimental effects and
has been reported in previous publications (Agar, 2016; Flythe et al., 2011). In light of this, renal nurses and
other healthcare providers involved in the care of HD patients must be made aware of the existence of A-IDH
(Daugirdas, 2015), the prevalence of both S-IDH and A-IDH, and the significant consequences of these adverse
events. Observed episodes of IDH, regardless of whether symptomatic or asymptomatic, need to be regularly
documented by the treating nurses to acknowledge, validate and emphasise the existence of these evidently
harmful events. Fundamental knowledge in this specific area might be beneficial to understanding the “bigger
picture” and may encourage renal nurses toward improved patient care and outcomes.
In contrast, postdialytic overhydration (OH) was considerably less commonly observed than IDH. Despite
Indigenous Australians proportionally experiencing the most IDH events, this ethnic group also had twice the
risk than Caucasians to cease their first treatment of the week in an overhydrated fluid state. This could be due
to the fact that these individuals generally are known to struggle more with fluid intake limitations over the
weekend break. As Cass et al. (2002) have reported, there exists serious miscommunication between
indigenous patients and non-indigenous healthcare workers in the quest to better adhere to and understand
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treatment goals in the dialysis setting. Modelling showed that haemodialysis patients had a more than five
times higher chance of OH on the first day of the week (Monday or Tuesday) than on the last day of the week
(Friday or Saturday). This fact could potentially be due to renal nurses trying to place a careful limit on
maximum UF goals on the first day of the week to avoid adverse events such as IDH, even when excessive fluid
has been accumulated over the longer weekend interval. Anecdotally, such pre-emptive measures are known
to occur when patients have no residual urine output, which dramatically limits their daily fluid intake
allowance. Diabetics and patients diagnosed with hypertension had a higher risk of experiencing overhydration
when compared to other causes. This may correlate with higher thirst distress occurring within this specific
cohort of patients (Kara, 2016).
Other authors have previously described IDH as the most common intradialytic adverse event (Rocha et al.,
2015; Stefansson et al., 2014). The results of this study have now confirmed this at the local level as well,
showing an unacceptably high prevalence of IDH and highlighting the need for more objective fluid parameters
to be made available to renal nurses. Due to a lack of accurate and objective fluid measures, renal nurses can
only roughly estimate how much UF can be too much for an individual patient they treat. It also indicates the
need for further education regarding the adverse effects of IDH and the identification of A-IDH events, aimed
at decreasing the negative effects of these individual episodes on renal patients.
This study on the prevalence of IDH revealed and confirmed similar findings to previous studies (Rocha et al.,
2015; Sands et al., 2014) where diabetics, females, indigenous and individuals with high UF goals had an
increased risk of experiencing episodes of IDH. Therefore, renal nurses need to be more alert of these specific
risk factors in order to identify subgroups of their patients with a heightened risk of IDH. Addressing potential
knowledge gaps around the frequency of adverse events and patients most at risk could potentially lead to a
paradigm shift in patient care. This new knowledge has potential to increase discussion amongst renal nurses
and their patients at handover meetings and upon treatment initiation. Focusing their attention on this
obvious problem could be one of the key features of future efforts to improve outcomes for patients.
In summary, renal nurses initiate treatments, decide on UF goals and UFR, and constantly observe patients
during haemodialysis. Therefore, they need to be better equipped with knowledge about UF, BP and the
negative impact of IDH, whether combined with symptoms or not. They are ideally placed to reflect on current
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clinical practices, apply their critical thinking and implement new preventative strategies for IDH. Ultimately,
satellite haemodialysis clinics need to have more effective preventative strategies and policies in place to
reduce the prevalence of IDH amongst their patients. This should lead ultimately to improved health outcomes
for patients and should enhance their quality of life.

7.2.3 The educational programme for renal nurses to perform IVC-US and to attain
competency
The development of a structured four-stage educational programme was another important achievement
during this study. As it is essential that renal nurses can independently perform IVC-US and subsequently use
these findings for patient assessments, it was critical that this programme covered all relevant aspects of IVCUS. The programme was developed in order to transfer the knowledge and skill of performing and interpreting
IVC-US scans. In collaboration with a sonologist, it was demonstrated that a renal nurse could master the skill
of using IVC-US and interpret IVC-US results for intravascular volume assessment.
The theoretical framework by Benner (1984) has provided a solid foundation for the educational programme
in this research. The structured pathway from theory to practice of a new clinical nursing skill, increasing in
complexity over time culminated in technical competency of the new skill for the renal nurse. Further, the
application of critical thinking and using IVC-US results in the context of other fluid-relevant clinical findings
demonstrated proficiency of the renal nurse. Once competency in IVC-US is achieved and clinical findings are
used in addition to other fluid-related parameters, IVC-US could be included in the daily fluid assessment
routine in in- and outpatient haemodialysis clinics. Outpatient clinics in Australia often lack medical support for
spontaneous fluid assessments and IVC-US could be particularly useful in this specific setting.
The first stage of this programme consisted of didactic training delivered by the sonologist and covered
physiological principles of the IVC including dynamic changes during different volume status. This stage also
included the technical handling of the ultrasound device, probe position and storage and transfer of recorded
scans. The second stage aimed for the practical demonstration of the technique of IVC-US to the nurse in the
clinical practice setting before, in the third stage, the renal nurse performed 100 IVC-US scans under
supervision by the sonologist. In the fourth and final stage, two independent experts assessed the renal nurse
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for competency. After successfully passing all four stages of the educational programme, the renal nurse was
deemed competent to perform IVC-US by the two independent sonologists. These findings may have
significant implications for clinical practice in future, in that the IVC-US technique could potentially also be
transferred to other renal nurses.
Applying this programme to a larger group of renal nurses in educational initiatives should be the next useful
step in introducing this additional fluid assessment method on a broader level in multiple satellite dialysis
clinics. This novel educational programme offers a unique opportunity to enhance other renal nurses’ skills
and encourage more accuracy in critical decisions for potentially improved patient outcomes. It has been
found that this programme enabled the facilitator, in this study the sonologist, to transfer the skills to an
ultrasound-naïve renal nurse. This renal nurse is now IVC-US competent and also has the potential to act as a
prospective facilitator to teach other renal nurses in attaining the skill of IVC-US, using the same approach as
this programme. As this approach was practical and provided a positive learning outcome, initially adhering to
the same structure and using the same number of preliminary scans should then demonstrate competency in
IVC-US in other renal nurses and validate the educational programme. This might appear at first as an onerous
task considering the large number of necessary scans initially, but this would be essential for a solid foundation
in such a repetitive task. Subsequent iterations of the educational programme would enable the trainer to
ascertain the optimal number and type of scans required to achieve competency. It is accepted that individual
perception in learning a new skill may vary and one may take a longer or shorter time to attain competency,
but adding another element to the renal nurses’ skill set could be a strong motivator to embark on this
journey. It is expected that once competent, trained renal nurses would then be able to share their knowledge
and act as facilitators in the same way and IVC-US could potentially become a generally applied technique by
the majority of renal nurses.

7.2.4

Assessing nursing competency in volume assessment using IVC-US

Once the educational programme was completed and the renal nurse deemed competent in IVC-US, it was
then necessary to evaluate mastery in the skill of performing and correctly interpreting IVC-US with point-ofcare ultrasonography on patients receiving HD in a trial. This trial resulted in good interrater agreement
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between the nurse and the experts’ findings, reported earlier. It was concluded that an ultrasound-naïve renal
nurse could be successfully taught how to acquire, measure and interpret ultrasound images of the inferior
vena cava. It was also demonstrated that, through multiple repeated performances of IVC-US in the same
anatomical area, a non-expert in the skill of ultrasonography could obtain a valuable non-invasive skill. It
further showed that the nurse was able to perform this skill independently from expert supervision, resulting
in consistently correct visualisation of the anatomical area of interest. The recorded scans were retrospectively
reviewed by two independent blinded experts, who then confirmed an accurate interpretation of the
visualised fluid status by the renal nurse. It is suggested that the transference of skills would be complete
when the newly competent renal nurse would then, after practice and experience, assume the role of the
independent expert and subsequently confirm interpretations of scans performed by those renal nurses
undergoing training.
These interpretations, based on the performed scans, would elicit critical information for the treating nurse,
and in combination with other clinically relevant parameters like blood pressure and heart rate, could lead to a
more holistic approach when assessing volume parameters and treatment goals. Adding this visual and noninvasive dimension to the traditional and established parameters of standard treatment could ultimately help
with the often-difficult decision making processes by the nurse. Renal nurses with improved skills for objective
volume assessment would be likely to better understand underlying anatomical conditions, and be more
inclined to deliver a less troublesome treatment to patients. This in return, may lead to improved health
outcomes for patients, such as avoiding subsequent hospital admissions and reducing cost.
In summary, for preparation of the pilot study, it was found that the structured educational programme
devised in conjunction with an expert sonologist for an ultrasound-naïve renal nurse was successful in
upskilling the nurse to perform ultrasound on the inferior vena cava.

7.2.5

Predictive value of IVC-US and BIS when observing for intravascular volume

Learning about the detrimental effects of IDH episodes led to a critical review of the current standard nursing
practice of fluid assessment prior and during HD. Whilst good clinical nursing assessment and monitoring of
the dialysis patient remains important in the attempt to avoid IDH, adding objective measure of fluid balance
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measurements may enable more accurate predictions. It was found that available objective parameters are
sometimes insufficient and misleading when used for a symptom- and burden free treatment. Adding further
objective parameters to define a more precise UF goal would have been useful and could also have been
potentially preventative for episodes of IDH.
The final stage of this research project was a simulative pilot study, where the ultrasound-competent renal
nurse compared the usefulness of additional IVC-US measurements with BIS and traditional clinical fluid
assessment methods. This study demonstrated that IVC-US and BIS were in agreement and that both would
have predicted episodes of IDH. During this study, simultaneous BIS and IVC-US scans were attained over the
course of a single treatment session on 30 patients and findings from these on pre- and intradialytic
intravascular volume status were compared with the traditional clinical assessment method. Significantly, GEE
modelling revealed that there was an almost 14-fold chance of an event of IDH in patients where IVC-US
indicated hypovolemia during treatment compared to those subjects where IVC-US indicated euvolemia.
Comparing the two methods of IVC-US and BIS revealed that both provided important information which could
have been potentially useful in directing the nurse to change the current treatment and potentially avoid an
adverse event. This last stage of this project also revealed that IVC-US can adequately estimate the
intravascular volume status and its findings initially correlated with those of BIS. However, while BIS can only
be performed prior to HD and display only an estimated forecast of the expected postdialytic fluid status, IVCUS can display intravascular volume status during a HD session and therefore could hold an informative
advantage over BIS at any given intradialytic time. Nonetheless, it was found that both methods had good
predictive value for the occurrence of IDH and that a specific algorithm to predict IDH could be derived that
would be useful in predicting IDH.
This algorithm, a combination of four specific elements and thresholds has potential to have fundamental
importance for the prevention of IDH. It comprises of a MAP < 70 mmHg, an UFR> 900ml/hr, and IVC-US and
BIS indicating hypovolemia, detailed below.
1.

MAP < 70 mm Hg, or

2.

BIS indicating hypovolaemia, or

3.

IVC-US indicating hypovolaemia, or
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4.

UFR >900 ml/hr

Two of these parameters already exist in the standard pre-clinical assessment of HD patients. The UFR is set by
the renal nurse and MAP is derived from the patient’s blood pressure. Pre-dialysis BIS was achieved through
the use of the Body Composition Monitor (BCM - Fresenius), a device available on-site but generally unused by
renal nurses in the clinics of this study. In simulation, adding IVC-US to these three elements showed
application of this specific algorithm would have been predictive for all IDH episodes in this study. This
algorithm predicted 11 episodes of IDH, 10 of which occurred. In the one case where the predicted IDH did not
occur, tests indicated hypovolemia. This is significant, as this has not been previously reported in any other
studies. For this patient cohort of 30 subjects, this algorithm showed a sensitivity of 95% and a specificity of
100%, which is an exceptional accuracy in such complex circumstances.
This study found that both IVC-US and BIS provided additional information that nursing staff could integrate
into their patient assessment to best determine the UF goals and UF rates required. Further, when comparing
both additional methods, they were in agreement, with IVC-US having the same predictive value for the
occurrence as BIS. It is noted that none of the additional elements of the algorithm on their own would have
been pre-emptive for every episode of IDH. However, this research found that combining IVC-US with BIS and
traditional predialytic clinical assessment plus using MAP values would have been predictive and preventative
for every episode of IDH. This is a significant result and should be explored further in future research.
Considering the characteristics and limitations of IVC-US and BIS, IVC-US holds some advantages over BIS. BIS
can only be performed prior to a HD session providing simply an estimate for excess fluid but is unable to
monitor fluid shifts occurring during HD. In addition, whether this estimated excess fluid is ultimately removed
depends on sign and symptoms displayed by the patient during the treatment. This is where IVC-US holds a
clear advantage over BIS, as it can provide accurate real-time intradialytic information to the observer,
whenever it may be needed and in a swift and non-invasive way. Therefore, it could be assumed that IVC-US
has eventually the potential to reduce morbidity and mortality in HD patients. Further, existing but unused
strategies such as BIS could be reintroduced as a potential assessment tool with nurses being supported with
evidence, creating an opportunity for better practice achieving better patient outcomes. With the addition of
IVC-US, renal nurses would be able to use both these devices in a safe manner, allowing for a self-reflective
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review of their routinely delivered nursing care in light of observations made when different methods are
applied. IVC-US might initially appear to be more difficult to master than BIS and will require more initial
investment from additional stakeholders, but it has been shown in this study that regular, routine use results
in competency. Both methods, IVC-US and BIS require additional initial operator training and completion of
training for BIS may be faster achievable than for IVC-US. However, initial cost for an ultrasound device or the
BCM are similar and POCUS devices may already be readily available for complex AVF cannulations and they
could potentially also be used for IVC-US. The investment in any of the devices and the operator training
should be worthwhile and could outweigh the potential benefits in avoiding episodes of IDH causing
hospitalisation and detrimental health effects.
Also, this study has shown that IVC-US is not just the domain of a specialist, and other health care
professionals can gain competency when receiving adequate guidance. Despite multiple technical advances
that have evolved in HD equipment over the past few years, intradialytic hypotensive adverse events still occur
frequently. It seems to be crucial that these technical devices are applied on an ongoing basis, although it
would be difficult to ascertain how frequently they are applied in individual dialysis units. IVC-US, in particular,
clearly has the potential to change policy and procedures if applied on a larger scale and if renal stakeholders
take ownership and apply this new knowledge.

7.2.6

Summary of major findings

Although the learning process to attain competency in the skill IVC-US for a renal nurse, including the correct
interpretation of the scans, was time-consuming and challenging, it was worthwhile due to confirming its
predictive value for IDH. This study has further implications for practice, as it has revealed that predialytic fluid
assessment by renal nurses has needed more accurate parameters when aiming for accurate predictions of
achievable euvolemia. It has also demonstrated that renal nurses may need comprehensive education to
enhance their understanding and knowledge of excess fluid and intravascular fluid shifts during haemodialysis.
Educating renal nurses in the use of IVC-US is an achievable goal if the learning process occurs in incremental
steps, allowing for sufficient reflection and feedback on achieved stages under the guidance of an expert.
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Results from this research have provided important information which could be useful in multiple ways. Firstly,
it confirms that both symptomatic and asymptomatic IDH still remain the most common adverse event during
HD, as previously described in many other scientific publications (Rocha et al., 2015; Schiller et al., 2015). The
prevalence rate of IDH remains unacceptably high at both local and global levels. It seems that the renal
community may sometimes become complacent and accept that IDH is an innate feature of the treatment,
regarding it as occasionally unpreventable. Current measures for the prevention and identification of IDH are
insufficient and more education for renal nurses is needed regarding the early recognition of IDH and
enhancement of existing preventative measures (Bradshaw et al., 2015). It is essential to be vigilant for
episodes of A-IDH when generally observing patients for IDH, as these have the same harmful effects as
symptomatic episodes (Bradshaw & Bennett, 2015). This underscores the fact that IDH may be generally
underreported and, as a result, particular episodes of A-IDH may have no consequences for a change in
current nursing practice.
Additionally, more critical thinking amongst renal nurses may be required when aiming for improved health
outcomes for patients. This includes renal nurses being more pro-active in improving the clinical outcomes
from treatments they deliver to their patients. There exists a variety of technical devices and features built
into HD machines and technical devices which could be more frequently used, including BVM, BIS, LUS and
IVC-US (Mullangi et al., 2018). A recent national practice prevalence survey undertaken amongst HD units in
the United Kingdom (UK) revealed that 78% of these units had no agreed policy for managing fluid balance in
patients receiving HD (Dasgupta et al., 2016). Forty-four percent of the examined units did not assess fluid
routinely and clinical assessment was the norm. These authors concluded that “There is an urgent need for
establishing an evidence base on the optimal approaches to fluid management” (Dasgupta et al., 2016). This
underscores again the necessity of more accurate and reliable fluid parameters in the day-to-day HD practice
and the need for ongoing education and future research.
This new knowledge could possibly be used by nurse educators or clinical leaders to advance skills for renal
nurses and set a path to delivering improved patient care. By keeping the focus on enhanced patient
surveillance, this may translate to improved health outcomes for patients. It is considered the results of this
study would be generalisable beyond the scope of the satellite clinics.

98

7.3

Limitations

This thesis was limited to two HD satellite clinics in the wider Perth Metropolitan area. Patient cohorts at
tertiary hospitals receiving maintenance HD may present with additional and more complex health issues.
Hence, results from this project may still be generalisable to other clinics, but caution should be exercised in
their interpretation. Other local or global HD satellite units may also use different fluid assessment methods
such as BVM, which can also be effective (Leung, Quinn, Ravani, & MacRae, 2014), but was beyond the scope
of this thesis. Additionally, there might exist different strategies or preventative pathways for IDH in some
units in Australia, and these have already established methods to observe patients for early signs of imminent
IDH (Bradshaw et al., 2017), however these were neither discovered nor explored during this project.
This thesis is further limited to the education of one renal nurse in the skill acquisition of IVC-US. An
educational programme was created and the renal nurse did achieve competence, however future research
will need to demonstrate if these skills and knowledge are transferable to other renal nurses, could they be
educated in a similar way, and would competency be achieved. The nurse in this study was highly motivated to
master the skill of IVC-US and achieve competency. Motivation may vary within a larger group of renal nurses
and this may impact on their attainment of this particular skill, however this would also warrant further
research.
Cardiovascular conditions such as pulmonary hypertension, right heart failure and tricuspid regurgitation may
influence CVP and subsequently results of IVC-US measurements (Simoni et al., 2016). It is therefore
recommended to consider any IVC-US results for patients with any of these diagnosed conditions in the clinical
context of other objective volume indicative parameters as well. It is also likely that patient cohorts may differ
locally and/or globally, depending on dialysis vintage, nutritional status, causes of chronic kidney failure and
other factors. Hence, results of these observations might appear differently.
Data collected during the 3-month phase where prevalence of IDH episodes was measured did not capture
data on some factors such as dialytic age, antihypertensive medications and residual urine output from
participants, so their significance as contributors to IDH could not be assessed. Additionally, IBW assessments
and adjustments during this study period were only based on the clinical findings by nurses and could not be
validated with BIS. The sample sizes in the patient cohort of the IVC-US vs BIS study and in the interrater
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reliability study were comparably small, with 30 and 10 participants respectively, and both studies were
conducted as pilot studies. Further sufficiently powered cohorts would inform the results derived from this
study.
BIS also has some limitations, where it measures the total body water but cannot discriminate between
intravascular water volume in the plasma and that in the extravascular compartment. The use of BIS has also
been cautioned by Davenport (2013), as overzealous reduction of IBW based on BIS measurements alone
could ultimately lead to loss of residual urine output function. Further, other authors have suggested that BIS
underestimates volume removed from the trunk and marked obesity can deliver unreliable results (Alexiadis et
al., 2017).
Whilst conducting this project, it was noticed that there was some resistance from clinical staff for this
research to be undertaken, perhaps for logistical and/or personal reasons. Previous studies have
demonstrated that nurses, although required to participate in continuing education, are sometimes unwilling
or unable to leave clinical settings to do so (Coventry, Maslin-Prothero, & Smith, 2015). Nursing research might
also not be well supported by some nurse unit managers as it could potentially distract the nurse from their
regular nursing duties, and this has been identified as a common barrier (Bonner & Sando, 2008).

7.4

Recommendations for policy, practice and research

7.4.1

Policy

It is essential to provide renal nurses with more specific education to increase awareness of the overall
negative consequences of each episode of IDH. This, in combination with highlighting the opportunities for IDH
prevention, must receive more attention from everyone in the renal team. This includes regular and accurate
documentation of S-IDH and A-IDH events according to commonly agreed definitions. Reviewing these
documented observations on a regular basis and comparing them with existing preventative IDH strategies
should reveal for each site the efficacy of their individual IDH prevention strategy. It is suggested that adding
more objective parameters into the UF volume decision-making process prior or during HD sessions may
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certainly help to reduce IDH events. Regular education sessions covering the major topics such as causes and
consequences of IDH, preventative methods and the review of unit-specific guidelines may help to raise
awareness of IDH at the local level. Additionally, introducing this topic at national and international renal
nursing conferences may have a positive effect on renal nurses’ individual knowledge and perception and may
subsequently influence their daily work practice. This may then initiate discussions within renal nursing teams,
encouraging critical thinking and reflection on current applied nursing practices, ultimately affecting renal
nursing policies.
7.4.2

Practice

The new knowledge about the prevalence rate of IDH and the increased risk for subgroups of patients has
potential to open up discussions amongst renal nurses and their patients at handover meetings and upon
treatment initiation. Therefore, all relevant aspects of the decision-making process by nurses upon treatment
initiation should be a most important subject for future research studies.
This research has also revealed that current nursing assessments on fluid status may lack reliable, accurate and
objective parameters, which are crucial for the delivery of a safe and uneventful treatment. Therefore, more
consistent information is needed prior to and during HD sessions, to make necessary adjustments and to tailor
treatments to the individual (Agar, 2016). The lack of objective parameters for fluid assessment is problematic
and can lead to further complications for the patient. Using IVC-US as an adjunct to clinical fluid assessment
has the potential to lead to better patient outcomes. The pervasion of a one-size-fits-all approach,
encountered at least in the satellite clinics of this study, should be re-examined in terms of current nursing
practice. Particularly, the commonly observed approach of 1000ml/hr UFR should be reconsidered for its
safety and its potential consequences on clinical outcomes, such as IDH, needs to be re-evaluated. Knowledge
evolving from recent research should be translated into enhanced clinical practice. This could be potentially
achieved with specifically targeted education seminars or conference presentations for renal nurses and
affiliated healthcare professionals covering the topic of IDH as the most frequent intradialytic adverse event.
This novel approach of renal nurses using intradialytic IVC-US has the potential to change clinical practice,
especially if this skill could be successfully transferred onto other renal nurses. Notwithstanding some
limitations of this project, it was shown that a satellite-based renal nurse could use IVC-US to potentially
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improve patient outcomes. It was further demonstrated that once the skill of obtaining and interpreting
ultrasound scans was achieved, it did not have to remain within the purview of the medical profession.
Nonetheless, an essential element for the outcome of this research was the inclusion of the medical specialist,
the sonologist, who initially directed the learning process. This emergency specialist was also a medical
sonographer with complex technical skills, and enabled the skills transference of image acquisition and clinical
interpretation of the obtained scans. Transferring this knowledge to the ultrasound-naïve nurse was crucial to
make this project successful.
Looking forward, theoretically and practically IVC-US is an excellent non-invasive adjunct diagnostic tool,
especially for real-time assessments of the intravascular fluid status. It could be used in every satellite dialysis
clinic if an ultrasound device with a suitable transducer was on hand. POCUS devices are today often readily
available in most satellite HD clinics (Mullangi et al., 2018), mainly to provide renal nurses with a non-invasive
and swift support for complicated cannulations (Marticorena et al., 2015). When available, they are frequently
and regularly used and renal nurses have adopted this tool as part of their daily clinical practice. The use of
POCUS devices has already advanced the renal nurse’s skill set and added another essential component to
improvement of direct patient care. Multiple studies in other clinical areas have demonstrated that specialised
nurses from heart-failure clinics can successfully learn and apply the skill IVC-US (Dalen et al., 2015)
(Gustafsson et al., 2015) and this has now also been proved in the renal nursing profession.
7.4.3

Research

Further research is needed for several topics resulting from this thesis. Future research investigating the
prevalence of IDH will also need to include data on the residual urine output in HD patients, as this will most
likely affect treatment goals and the likelihood of IDH events. To date, residual urine output in HD patients and
its correlation with IDH has not been the focus of many renal research projects, although residual urine output
plays a significant role in the quality of life for this patient cohort.
Another important topic for prospective studies is the process of decision making of renal nurses for individual
UF goals. Anecdotally, this fundamental process varies somewhat amongst renal nurses and highlights the
range and scope amongst individual nurses, who at times would assess the same patient differently for fluid
status. This difference then has the potential to result in differing UF goals, subsequently affecting the
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occurrence of IDH. Therefore, all relevant aspects of the decision-making process by renal nurses upon
treatment initiation should be an important subject for future nursing research studies. Of further interest in
this context would also be the observation of the process in finding and establishing individual IBW targets for
patients including regular review. It is likely that there exists a broad variety of approaches in a variety of
clinical practice settings in satellite clinics and how IBW’s are generally established. This includes finding an
agreement on IBW’s through interprofessional conversation between renal nurses and renal consultants, and
the renal patients who are sometimes included in this discussion.
It is now suggested that future research studies should investigate, on a larger scale, the transferability of the
skill IVC-US by the trained nurse or a sonologist to other renal nurses. This research would explore if IVC-US
during a haemodialysis session could be successfully performed, including correct conclusions drawn from the
obtained scans and if this research would provide similar outcomes for operators. It should also be
investigated if motivation to attain this skill varies amongst renal nurses and if this would affect outcomes.
As this simulative pilot study comprised of a relatively small patient cohort, future research will have to
demonstrate whether IVC-US could hold an advantage over BIS when using these methods for the prevention
of IDH. Most importantly, the algorithm derived from this research needs to be tested on a larger scale and
warrants further exploration in the future, such as a randomised controlled trial comparing IVC-US and the
proposed algorithm against standard clinical practices.
Several other aspects for future studies evolve from this thesis. A comparative study exploring the cost, time
and operator training required for the three different fluid assessment methods which includes patientreported outcomes, dialysis tolerability and which measures the inter- and intradialytic quality of life of
haemodialysis patients would be warranted. Future studies may also investigate the detrimental effect of IDH
episodes on cardiac and cerebral function, measured either per episode or observed over time in the most
affected patient cohort (McIntyre & Goldsmith, 2015).
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Chapter 8
8.

Conclusion

Several milestones were achieved during this project and each step provided new evidence to address some of
the complexities within the field of fluid assessment in haemodialysis patients. This included a skill that is
readily attainable by renal nurses.
The systematic literature revealed that renal nurses have not previously used IVC-US on haemodialysis
patients to objectively assess their fluid status. However, it also revealed that IVC-US can be a useful objective
method to assess a patient’s fluid status and other specialised nurses have successfully used ultrasound in
their clinical speciality. Adding asymptomatic IDH events to symptomatic IDH events increased the prevalence
of any IDH episode by almost a third during a three-month observational period. This underscored the
importance of including symptom-free events when observing for IDH.
Knowing that multiple episodes of IDH are causing a multitude of detrimental patient outcomes, it became
clear that renal nurses need more objective, accurate and reliable fluid assessment methods for the successful
prevention of these adverse clinical incidents. IVC-US allows for a real-time visual observation of intravascular
volume status in HD patients which directly correlates with both CVP and the well-being of a patient during
treatment and could be an ideal addition to the skill-set of a renal nurse. Moreover, this project demonstrated
that a staged education programme can be a valid and successful method to achieve competency for a renal
nurse in the use and application of IVC-US. The application of IVC-US by the renal nurse in the last stage of this
project demonstrated a potentially high level of usefulness for prevention of IDH. When compared to and used
in conjunction with another established fluid assessment technique, BIS, both provided similar results.
This study has shown that current fluid assessment methods have limitations and more objective parameters
to establish evidence for the optimal approaches to fluid management are needed. IVC-US is first and foremost
a superior assessment tool to others as it can be used as both a pre-emptive assessment tool pre-dialysis and a
proactive diagnostic tool intra- and post-dialysis. This research demonstrated that nurses can effectively
acquire complex skills usually reserved for the medical profession, and it further showed that using these skills
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could provide useful additional information when combined with other fluid-related parameters. This
information could be critical when renal nurses strive for prevention of episodes of IDH.
Initially, this project set out to explore whether renal nurses could safely and efficiently perform IVC-US on HD
patients during their treatments to obtain an objective assessment of their fluid status, and if these findings
could potentially lead to improved health outcomes for patients. This was confirmed with the renal nurse
acquiring competency to assess patient fluid status. Thereafter, it was possible to demonstrate in a simulative
pilot study that IVC-US had the same predictive value for the occurrence of IDH episodes as BIS, but it could
also provide a real-time intravascular volume trend at any intradialytic moment, holding an advantage over
BIS. The pilot study allowed for a low-risk and meticulous observation of the potential impact of IVC-US,
performed during HD treatment, compared in parallel with BIS and traditional clinical predialytic assessment
methods. If the information provided by IVC-US in the pilot study had been available for the nurse who
performed the HD, and they had initiated prompt preventative measures, the incidence of IDH episodes would
have been significantly reduced.
However, this study has also revealed that although IVC-US could deliver important and essential information
to the observer, it should not be used as the sole parameter for intravascular volume assessment. It should
always be seen in the clinical context and as an adjunct to other objective parameters. When IVC-US is used in
conjunction with two readily available clinical elements and BIS, and applied as a simple clinical algorithm, it is
strongly predictive of the majority of IDH episodes.
Results of this thesis have created a unique and original contribution to nursing research, including the
compilation of a learning package for future nurses who may aim to attain the same skill. Further, in
simulation it was possible to demonstrate the value and the potential of IVC-US skills in making a positive
impact on the clinical outcomes of HD patients.
The addition of IVC-US as another clinical dimension for assessing fluid has the ability to change policy and
clinical practice in the future, given sufficient support from stakeholders and clinical leaders. It has good
potential to change clinical practice for pre- and intradialytic fluid assessment if applied by more renal nurses
on a broader scale.
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There are constraints around its use, due to resource and logistical limitations, but it is recommended that IVCUS should at least be used as an adjunct to clinical fluid assessments, where it could provide valuable
information and direct nurses to reassess their clinical decisions. A simple reconsideration of fluid
management might hold the key to improved patient outcomes. It might also instigate a critical assessment of
the local renal nursing practice and initiate reflection and discussion amongst nurses on patient outcomes. This
may ultimately contribute to changes in policy and practice, resulting in improved morbidity and mortality
outcomes for HD patients.
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